Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
6-9-2021 12:30 PM

3D Printed Polypyrrole Scaffolds for pH Dependent Drug Delivery
with Applications in Bone Regeneration
Matthew T. Lawrence, The University of Western Ontario
Supervisor: Price, Aaron D., The University of Western Ontario
Co-Supervisor: Séguin, Cheryle A., The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Master of Engineering
Science degree in Biomedical Engineering
© Matthew T. Lawrence 2021

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Biomaterials Commons

Recommended Citation
Lawrence, Matthew T., "3D Printed Polypyrrole Scaffolds for pH Dependent Drug Delivery with
Applications in Bone Regeneration" (2021). Electronic Thesis and Dissertation Repository. 7837.
https://ir.lib.uwo.ca/etd/7837

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

Abstract
Areas of large bone loss are typically healed using autologous bone grafts, seen
as the gold standard of care. These materials have a complication rate of 10–40%
during harvesting and are limited by the quantity available; therefore the use of 3D
printed polymer scaffolds as bone graft alternatives are proposed. Polypyrrole (PPy) is
a biocompatible electroactive polymer that has metal-like electrical properties that can
be harnessed to hold and release charged drug molecules, triggered by a change in pH.
pH fluctuations are seen inside the human body in areas of bone regrowth, which would
act as the triggering mechanism for drug release from PPy. PPy nanoparticles were
incorporated into hydrogel resins, capable of being 3D printed using stereolithography
techniques using riboflavin as a natural photoinitiator. Polymers were tested for drug
delivery capabilities, cell adhesion, and biocompatibility to ensure proper function. These
composite polymers were successful as a potential material for synthetic bone grafts.
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Summary for Lay Audience
3D Printing is revolutionizing the manufacturing of medical devices, allowing the
production of patient-customized devices with unique shapes. Bioprinting refers to
the application of 3D printing alongside the incorporation of cells, growth factors, drug
molecules, and biologics to create materials that mimic real tissues. One common
bioprinting material is hydrogels, classified as polymers that have a high affinity for
water. Hydrogels have been shown they are capable of supporting cell growth but
are not perfect and can have improved functionality by pairing them with a second
polymer. Polypyrrole was chosen as a copolymer because of its electrical properties
as a conjugated polymer, meaning it offers metal-like conductivity in a polymer. These
properties give polypyrrole the ability to store and release drug molecules, triggered by
surrounding pH changes. Interestingly, there are pH changes seen naturally in areas
of bone regrowth or regeneration due to the bone healing cycle. Using polypyrrole in
areas on bone regeneration could act as the triggering method for drug release from
3D printed scaffolds. In this study, we used 3D printing to create a hydrogel-polypyrrole
scaffold capable of pH-triggered drug delivery while supporting cell growth. The scaffold
was tested for drug delivery capabilities, cell adhesion, and biocompatibility to ensure
proper function inside the human body. These studies show the success of a 3D printed
biocompatible hydrogel-polypyrrole scaffold and could be further investigated as an
alternative to bone grafts.
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So often in life, things that you regard as an impediment turn out to be great,
good fortune.
–Justice Ruth Bader Ginsburg
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Dedication
Dedicated to all, as science is meant to be shared.
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Chapter 1
Introduction
The 3D printing of polymers has revolutionized the rapid production of customized
objects with complex microstructures. Applications of 3D printing are vast, but one of
the most promising areas of growth is the medical device industry. 3D printing allows
the creation of patient customized devices with a wide variety of properties, depending
heavily on the material chosen. Conjugated polymers (CP) have been investigated
for use in 3D printing applications due to their electrical properties created through a
backbone of alternating single- and double-bonds. This conjugated bonding structure
allows electrical conductivity, not typically seen in conventional polymers. Combining
electrically conductive polymers with the benefits of 3D printing would be optimal for the
creation of novel biomedical devices.
Polypyrrole (PPy) is an organic CP that has specific properties that can be modulated due to physical, electrical, and chemical stimuli. Given its electrical properties,
PPy has been utilized in medical research in neural devices, bone regeneration, and
tissue engineering (Vijayavenkataraman et al., 2019; Sajesh et al., 2013; Ateh et al.,
2006). One of the most promising applications has been as a drug delivery and biosensing material (Geetha et al., 2006). Previous studies have used PPy to store dopant
molecules based off redox reactions caused by voltage changes along the polymer
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backbone (Hosseini-Nassab et al., 2016). PPy also has the capability to respond to
changes in localized pH to release stored dopant molecules (Samanta et al., 2015).
These pH changes occur naturally inside the human body in areas of infections, chronic
wounds, and bone healing (Schneider et al., 2007; Chakkalakal et al., 1994). Harnessing
this pH change would allow PPy to “switch” on in areas of bone regeneration, triggering
the delivery of molecules inside the human body. Concurrently, research into bone graft
alternatives is increasing due to the relatively high complication rate during graft harvest
and limited supply of real bone tissue (Zeng et al., 2018). Given this previous research,
PPy would be an optimal candidate for synthetic bone grafts.
So far, few studies have combined the useful properties of PPy with the benefits
of bio-printing for bone regeneration applications. The poor processability of PPy has
limited the use of novel creation methods, thus curbing the biological applications
that this smart polymer can be used for. Although drug delivery with PPy has been
researched previously, these studies focused on the electrical stimulation of PPy, a
stimuli not normally seen within the human body (Hosseini-Nassab et al., 2016; Svirskis
et al., 2010; Wadhwa et al., 2006). Research on pH-dependent drug release of PPy is
sparse and requires further work to elucidate its full capability as a drug delivery vehicle.

1.1

Objectives

This thesis work aims to investigate the 3D printing of drug-doped PPy/hydrogel scaffolds
for applications in bone regeneration. To achieve this goal, the following research
objectives are purposed:
• Development of a biocompatible PPy resin. The first objective is to develop a
biocompatible resin with incorporated drug-doped PPy nanoparticles (NP) that is
capable of being printed using a novel stereolithography 3D printer in the Organic
Mechatronics and Smart Materials Laboratory (OMASML). Characterization of the
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printing parameters will be performed to offer optimized print resolution, allowing
the creation of complex micro-featured scaffolds for biomedical applications.
• Investigate PPy NP drug release conditions and characteristics. The second
objective is to elucidate PPy drug entrapment and release properties from this
drug delivery vehicle, focusing on biologically relevant pH values. PPy polymer
release data will be collected over an extended period to examine the timeline of
molecule release.
• Test the cytotoxicity and cell-interactions of the PPy/PEGDA resin for use as an
implant material. The final objective aims to demonstrate that osteoblast cells
have minimal cytotoxicity when exposed to this polymer as part of an initial safety
assessment. The second part of the biocompatibility tests include cell adhesion
tests to ensure viability inside the human body to act as a scaffold for rapid bone
regeneration.

1.2

Major contributions

This thesis communicates the following contributions to the scientific community:
• Novel PPy NP/Hydrogel photoactive resin. The first study of PPy NPs encapsulated in poly(ethylene) glycol diacrylate (PEGDA) created using additive manufacturing methods. The two-step creation method combines the advantageous
properties of PPy NPs into a photoactive resin blend, capable of being 3D printed.
The relationships between print parameters, print resolution and PPy concentration
were investigated. This research led to the creation of complex, high-resolution
PPy/PEGDA scaffolds with flexible microarchitectures for bone regeneration applications.
• Polypyrrole drug delivery of biologically relevant dopant molecules at physiological
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pH values. Dopant entrapment and release characteristics from PPy NPs in
PEGDA hydrogel scaffolds were successfully tested over a range of physiological
pH values. The release capabilities of the PPy/PEGDA scaffolds have shown the
pH-triggered switching parameters, optimal for in-vivo drug delivery applications.
• Biocompatibility and cell adhesion testing of the PPy/PEGDA formula. Testing
of the novel PPy/PEGDA resin with MC3E3-E1 pre-osteoblast cells allowed both
the cytotoxicity and cell adhesion interactions to be investigated. There were
no cytotoxic effects from the PPy/PEGDA scaffold leachate over a 14 d period.
Additionally, the addition of PPy NPs improved the PEGDA cell adhesion. Given
these biological results, it has been shown that this novel resin blend and creation
methodology offers a flexible biomaterial for future studies.

1.3

Organization of the thesis

The following Chapter 2: Background outlines influential knowledge that has proceeded
this thesis, including relevant topics on bone physiology, hydrogels, CPs and additive
manufacturing. In accordance with the previously mentioned objectives, this thesis
is organized as follows: Chapter 3: PPy/PEGDA Composite Resin Creation explores
the creation and characterization of a PPy/PEGDA resin, using a natural photoinitiator,
riboflavin. Chapter 4: PPy/PEGDA Composite Resin Application, explores the applications of the previously described resins, including the 3D print resolution and drug
delivery capability in response to pH stimuli. Specifically outlining the dopant entrapment
and release characteristics, showing the vast biomedical applications with the use of
PPy. Chapter 5: Resin Biocompatibility Testing outlines the biological studies used to
ensure that the printed resin is capable of being used as a biomaterial. This is shown
through cytotoxicity and cell adhesion studies that explore the cell response to this
PPy/PEGDA polymer. Finally, Chapter 6 Concluding remarks summarizes the overall
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conclusions of this work, restating the major contributions to the scientific community,
and provides recommendations for exciting future work in the biomedical field for PPy.
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Chapter 2
Background
As outlined in Chapter 1: Introduction, this project aims to use additive manufacturing
techniques to create a PPy/PEGDA hydrogel scaffold, capable of drug delivery inside
the human body in areas of bone regeneration. This chapter outlines the necessary
information to understand this thesis. An introduction into the bone structure and bone
grafts is outlined and provides background into the over-arching application for this work.
Polymers, including both hydrogels and CPs, provides the groundwork for understanding
the biomedical applications of these materials. The current applications of PPy in the
medical field as a biomaterial are outlined, focusing on osteogenic studies. Finally,
research in bioprinting of hydrogels and PPy is presented and defines the current
problems of each type of material. The background chapter connects the topics of bone,
polymers, and additive manufacturing and how they relate to the following work.

2.1
2.1.1

Bone
Physiological Bone

Bone is one of the most interesting organs in the human body, stiff yet porous, rigid
yet constantly being remodelled. Bones are key in our day-to-day lives, necessary
7
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Figure 2.1: Schematic of bone architecture moving from the macro to the atomic scale,
highlighting the complex nature of bone tissue (© Nair et al. (2013), included with
permission).
for mobility, protecting vital organs, and providing calcium and phosphate homeostasis (Wang and Yeung, 2017). Bone has two distinct types: cortical and cancellous.
Cortical bone, otherwise known as compact bone, is the hard outer shell of bones that
provides rigidity and has a very low porosity value of 3–12% (Karageorgiou and Kaplan,
2005). Cancellous bone, also know as trabecular and spongy, is the inner portion of
the bone that is has a porosity between 50–90% (Karageorgiou and Kaplan, 2005).
Bone is highly vascularized with blood vessels, referred to as Haversian canals, with
rings of calcified bone encircling them called osteons, seen in Figure 2.1. The porosity
of trabecular bone allows for the delivery of cells and vascularization that are vital to
bone growth. It has been seen that the minimum pore diameter for bone vascularization
is 100 µm (Karageorgiou and Kaplan, 2005). The porosity values of bone impact the
electrical conductivity; cortical bone has a conductivity of 9.1 mS/m compared to bone
marrow region with a conductivity of 230 mS/m (Balmer et al., 2018).
Bone is comprised of extra-cellular matrix (ECM) and three main types of cells:
osteoblasts, osteoclasts, and osteocytes. The ECM contains both an inorganic matrix
in the form of hydroxyapatite, which provides compressive strength, and an organic
matrix component made up of 90% type 1 collagen and 10% non-collagenous regulatory
proteins (Clarke, 2008). Osteoblasts are responsible for the creation of bone, they
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synthesize new layers of ECM over the surface of the bone, encasing osteocytes into the
bone. Osteocytes are osteoblasts that have been fully surrounded by bone and facilitate
communication through cell signalling. Osteoclasts resorb bone through the excretion
of acidic H+ ions and cathepsin K enzyme, which break down the mineral and protein
components of bone (Clarke, 2008). These cells cause the localized pH environment to
fluctuate around areas of bone regeneration. The body has a natural buffer system that
maintains a blood pH of 7.4, anything less is referred to as acidosis and anything above,
alkalosis (Schneider et al., 2007). Chakkalakal et al. (1994) used a rat model to show
the acid/base switching seen in areas of large skeletal defects. In the first week after
injury, there was an acidic environment around the tissue, moving towards an alkaline
environment in the following three weeks, seen in Figure 2.2. These changes in pH
are due to which cells are prominent at each time point. The acidic environment is key
to osteoclast bone resorption of older ECM that may be damaged. Osteoclast activity
peaks at pH 7 (Galow et al., 2017). Conversely, osteoblasts have been shown to have
optimal activity when the pH is between 8.0

8.4 (Galow et al., 2017). The outlined

pH change is an important aspect of the chemical activity of bone grafts and it can be
harnessed as a natural stimulus to facilitate drug delivery from synthetic polymers.

2.1.2

Bone Grafts

Bone grafts are often used in areas of large bone loss, commonly seen in dentistry (Kumar et al., 2013). With little material left to support cell growth, there is room for bacterial
proliferation and slow bone healing. Trauma, infection, surgery or genetic conditions can
all cause bone defects, leading to bone being the second most common type of tissue
transplant, after blood (Kumar et al., 2013; Wang and Yeung, 2017). There is a large
area of research into the creation and testing of natural, artificial or synthetic bone grafts
to accommodate the tremendous demand. The goal of bone grafts is to eliminate dead
space and reduce the risk of infection post-operatively (Kumar et al., 2013). Laurencin
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Figure 2.2: A graph outlining the pH changes in the surrounding bone area after large
skeletal defects using a rat model. The change in pH is due to the bone resorption and
deposition cycle that is seen after trauma (© Chakkalakal et al. (1994), included with
permission).
et al. (2014) classified bone grafts into 5 main groups: Allograft-, cell-, factor-, ceramicor polymer-based, each with certain advantages. Successful bone grafts have three
main qualities that ensure successful osteoconduction (the ability for osteoblast cells
to attach and grow onto the surface of a material), osteogenesis (the ability to bridge
bone growth between the scaffold and surrounding cells), and osteoinductivity (the
ability for the material/scaffold to dictate differentiation of stem cells) (Laurencin et al.,
2014). One type of graft that meets all three osteogenic properties is the autograft
or allograft, bone harvested from the patient or donor/cadaver, respectively. Natural
bone is commonly used as a bone graft because it achieves optimal osteoconduction,
osteogenesis, and osteoinductivity and is seen as the gold standard for bone regeneration. This material is not collected without risk, between 10–40% of the harvesting
procedures reported complications such as nerve damage or hemorrhage (Zeng et al.,
2018). Depending on the size of the defect, there are drawbacks to using natural
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bone because of the limited material amount that can be collected (Zeng et al., 2018).
Another obstacle of using natural bone as an osteo-scaffold is the chronic shortage
of this valuable material (Beswick and Blom, 2011). Given these findings, there is the
need to investigate the use of alternative materials for bone grafts. Cell-based bone
grafts are either cell suspensions or cells seeded onto a scaffold that can be used to
create new bone, such as the differentiation of mesenchymal stem cells into osteoblastic
cells (Jaiswal et al., 1997). Factor-based bone grafts utilize growth factors, either natural
or recombinant, that increase the formation of new bone. Common growth factors are
bone-morphogenic proteins (BMP), proteins known for their osteoinductivity, especially
BMP-2 and BMP-7 (Laurencin et al., 2014; Bialy et al., 2017). BMPs are classified as a
transforming growth factor - growth that can be used to modulate bone growth (Bialy
et al., 2017). Both cell- and factor-based bone grafts are commonly paired with solid
materials, such as ceramics or polymers, to allow both structural support with the benefits of the cell- or factor-based therapy. Ceramics are often used as bone grafts due to
their similar compressive loading properties and can include bioactive glass, calcium
sulphate, and calcium phosphate (Laurencin et al., 2014). These materials are optimal
due to the incorporation of calcium being similar to that of the inorganic component of
bone calcium, hydroxyapatite. Finally, there are polymer bone scaffolds that offer the
largest customizability of both natural and synthetic polymer materials. Polymers can
be designed with specific mechanical and chemical properties. Common bone graft
polymers include poly(lactic) acid, poly(methyl methacrylate), poly(glycolic acid), and
poly(ethylene) glycol (PEG) (Haugen et al., 2019; Kaito et al., 2005).
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Hydrogels are defined as networks of hydrophilic polymers that are comprised of either
natural or synthetic chains that can be polymerized to form 3D structures (Unagolla
and Jayasuriya, 2020). Two types of cross-linking can be utilized in hydrogel creation. Chemically cross-linked hydrogels have been modified to connect monomers
permanently at junctions, whereas physical cross-linking relies on entanglement of
polymer chains, hydrophobic/hydrophilic interactions, and hydrogen bonds (Ahmed,
2015). Polymerization of these monomers can be achieved using heat, light, or chemical
polymerization methods depending on the given application (Ahmed, 2015). PEG is one
type of hydrogel comprised of repeating ethylene glycol monomers with various types of
end groups that functionalize the monomer (D’souza and Shegokar, 2016). PEG is a
bio-inert hydrogel, used for its ease of polymerization with Ultra-Violet (UV) light and low
cytotoxicity (Unagolla and Jayasuriya, 2020). PEG is commonly used in drug delivery
applications due to its ability to allow the steady diffusion of drug molecules inside the
human body (D’souza and Shegokar, 2016; Hokugo et al., 2014). In-vivo, PEG has been
shown to have low cell-adhesion and activation with little interaction with surrounding
tissues, leading to a negligible immune response (D’souza and Shegokar, 2016). It
should be noted that there have been extreme hypersensitivities to PEG, leading to
this material being unusable in this portion of the population (Stone et al., 2019). To
improve the success of PEG hydrogels as a tissue scaffold, recent studies have used
ECM-elements, copolymers and NPs to increase the bioactivity of PEG (Zhu, 2010).
These types of composite hydrogels overcome the previously outlined limitations of
conventional materials. Post-grafting of peptides or proteins provides cell-adhesion
cites (Drumheller and Hubbell, 1994; Lee et al., 2007). Copolymers, such as peptidemonoacrylates and -diacrylates, integrate into the hydrogel bulk, creating molecules that
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cells can attach to more efficiently than coatings (Zhu, 2010). NPs incorporated into
hydrogels offer increased cell-binding sites, modified mechanical properties, and secondary functionality depending on the NP chosen (Abalymov et al., 2020). For example,
Carles-Carner et al. (2018) added hydroxyapatite NPs to PEG-based hydrogels capable
of osteogenesis. A significant body of research has supported the use of hydrogels in
bone regeneration applications, commonly for cell or growth factor delivery (Gibbs et al.,
2016). For bone regeneration applications, researchers have incorporated biphasic
calcium-phosphate NPs into Gelatin-PEG hydrogels that were shown to have optimal
cell-adhesion and bio-mineralization, key for bone growth (Van et al., 2016). Kaito et al.
(2005) used poly-lactic acid and PEG co-block polymer with the addition of hydroxyapatite for a biodegradable scaffold used for bone regeneration. This study showed the
improved efficiency of BMP through diffusion but lacked a “smart” delivery system that
responded to physiological conditions. Fu et al. (2012) used a triblock co-polymer of
PEG-poly(✏-caprolactone)-PEG in conjunction with hydroxyapatite and collagen to show
that these hydrogels had good bone regeneration when compared against the self-repair
process. Although there is previous research into hydrogels for bone regeneration, there
is significant applicability for these materials when paired with CPs.

2.2.2

PEG Photoinitiators

One type of chemical cross-linking of PEG is through the use of light. The UV
light is used to excite photoinitiator molecules, classified as either cationic or freeradical (Zeng et al., 2021). Cationic, the less studied of the two methods, uses onium
salts to produce acids when light is applied, causing polymerization (Sangermano,
2012). Type 1 radical photoinitiation works through hemolytic cleavage from a UVexcited triplet state, whereas type 2 radical photoinitiators work in conjunction with a
co-initiator to produce radicals (Zeng et al., 2021). Common commercially available
photoinitiators are often cytotoxic (Nguyen et al., 2013; Zeng et al., 2021). Zeng et al.
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(2021) tested 7 common photoinitiators showing that phenylbis(acyl) phosphine oxides
had the largest cytotoxicity while Diphenyl (2,4,6-trimethylbenzoyl) phosphine oxide,
4,4’-Bis(diethylamino) benzophenone, and 2-Isopropylthioxanthone and 2-Benzyl-2(dimethylamino)-4’-morpholinobu tyrophenone, also known as Irgacure 369, all showed
cytotoxic effects that increased at higher concentrations, leading to a limitation in the
concentration used. Irgacure 2959, also known as hydroxy-1-[4-(hydroxyethoxy)phenyl]2-methyl-1-propanone, is widely regarded as a biocompatible commercially available
photoinitiator but has been demonstrated to be cytotoxic at concentrations over 0.015%
w/v (Sabnis et al., 2009). Additionally, the type of cell line used influenced these results,
Williams et al. (2005) showed that fetal human osteoblasts were extremely sensitive
to Irgacure 2959. Naturally derived photoinitiation methods utilize molecules such as
L-arginine (an amino acid), curcumin (turmeric root) and riboflavin (vitamin B2) (Kim
and Chu, 2009; Zhao et al., 2015; Mishra and Daswal, 2005; Nguyen et al., 2013). Most
interesting is riboflavin, a naturally occurring, non-toxic vitamin that has an absorption
spectrum between 300 and 500 nm with peaks at 365 and 448 nm (Nguyen et al., 2013).
The excitation of this molecule leads to the formation of a superoxide radicals, capable
of initiating several reactions (Batchelor et al., 2016). Riboflavin alone cannot trigger
PEG polymerization, a second co-initiator is needed. Kim and Chu (2009) utilized
L-Arginine as an electron donor in conjunction with riboflavin in the polymerization of
dextran methacrylate for biodegradable hydrogels. Dithiothreitol combined with riboflavin
initiated thiol-ene polymerization of PEG hydrogels (Batchelor et al., 2016). Nguyen
et al. (2013) used triethanolamine (TEA) as a co-initiator to riboflavin with a two-photon
3D printing method (described below in the Additive Manufacturing Section) to cure 3D
PEG polymers with no cytotoxicity seen with the LIVE/DEAD assay. Given this, there is
the need to investigate the use of riboflavin as a photoinitiator for the custom-designed
OMASML 3D printer.
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Conjugated Polymers

Conjugated polymers (CP), also know as Intrinsically Conducting Polymers (ICP), are
a special classification of polymer with unique optoelectrical properties that offer a
broad range of applications in the field of biomedical engineering (Bendrea et al.,
2011). Polymers are typically excellent insulators however, these types of CPs have
properties more similar to metals or semiconductors making them a distinct focus for
research (Hamzah et al., 2007). The field of CP research has experienced significant
growth after the awarding of the Nobel Prize in 2000 to Alan G. MacDiarmid, Alan J.
Heeger, and Hideki Shirakawa and their work on CPs (Shirakawa et al., 1977). CPs are
characterized by a backbone of alternating single and double bonds with delocalized

⇡ electrons (Hamzah et al., 2007). This arrangement leads to overlapping p-orbitals,
with ⇡ electrons that are allowed to move between two nuclei, otherwise known as
delocalized electrons (LibreTexts, 2020). The free ⇡ electron movement gives CPs their
conductivity due to their ability to move between nuclei, transferring electrical charge
along the polymer, unachievable in conventional polymers (Nezakati et al., 2018). There
are many types of CPs that have been researched and offer varying mechanoelectrical
properties and processability. They include polyaniline, polyphenylene, polythiophene,
and PPy, seen in Figure 2.3 showing the conjugated bonding structure (Nezakati et al.,
2018). One of the first well-studied CP was polyacetylene, this material was researched
in 1977 to be conductive after n- or p- doping, allowing an increased conductivity due to
the polymer entering a metallic-like state (Nezakati et al., 2018). The doping processes
incorporates impurities into the polymer matrix, modifying the electrical conductivity.
CPs have conductivities between 10

10

and 10

5

S/cm and up to 1 to 104 S/cm using

various dopants (Nezakati et al., 2018; MacDiarmid, 2001). The increase in conductivity
overlaps with the range of metal conductivities between 10

4

to 106 S/cm (Nezakati

et al., 2018).
There are two common creation methods for CPs: chemical or electrochemical

C HAPTER 2. B ACKGROUND

16

Figure 2.3: Chemical structures of common conjugated polymers that show the
conjugated bonding arrangement of alternating double and single bonds that give rise
to conductivity (© Nezakati et al. (2018), included with permission).
polymerization (Hamzah et al., 2007). During electrochemical creation, two electrodes
are placed in a solution containing the solubilized monomer and an electrical potential is applied, causing a redox reaction to polymerize the polymer on the surface of
the working electrode (Qu et al., 2004; Liubchak et al., 2020). This creation methodology results in thin films on the working electrode, commonly used to coat devices
such as medical implants (Rikhari et al., 2020). Electrochemical synthesis offers the
creation of highly conductive coatings with the ability to create complex hierarchical
structures (Liubchak et al., 2020; Qu et al., 2004). Chemical polymerization uses an
aqueous oxidant in a solution that contains solubilized monomer where a resulting redox
reaction connects the individual monomer units into a polymer that is dispersed in the
creation solution (Leonavicius et al., 2011). Synthesis using chemical processes usually
results in a large quantity of polymer that is scalable at a reasonable cost (Hamzah et al.,
2007).
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poly(p-phenylene)
polyaniline
polythiophene
polypyrrole
polyacetylene

17
Chemical Formula
[C6 H4 ]n
[C6 H4 NH]n
[C4 H4 S]n
[C4 H2 NH]n
[C2 H2 ]n

Conductivity (S/cm)
10 3 102
10 2 100
100 103
2 100
105

Table 2.1: Common conjugated polymers with their chemical structures and ranging
conductivity values that are a result of the structures described in Figure 2.3 Nezakati
et al. (2018).

2.2.4

Polypyrrole

The most interesting CP to the OMASML group is PPy, an organic and biocompatible
polymer that yields a high conductivity compared to other CPs (Wang et al., 2001;
Nezakati et al., 2018). PPy is the polymer form of pyrrole, an organic compound that has
an aromatic heterocyclic structure (Nezakati et al., 2018). During polymer formation, two
pyrrole molecules each eliminate two hydrogen molecules, the free electrons are then
able to bond to each other, creating sigma bonds between each aromatic unit (Street
et al., 1985). PPy is similar to other CPs in that it has poor processability after creation,
unable to be fused or solubilized, which restricts its applications (Wang et al., 2001).
PPy is known to be brittle with no crystalline structure, leading to it being classified as
an amorphous polymer (Fonner et al., 2008). The presence of dopant molecules in
PPy chains can change the biocompatibility, cell adhesion, conductivity, and chemical
exchange properties (Fonner et al., 2008; Bendrea et al., 2011; Jovanović et al., 1995).
Unlike other CPs, PPy is used most often in biomedical applications due to its biocompatibility with many cell types, such as catecholamine cells, Schwann cells, osteoblasts,
and fibroblasts, and is capable of supporting local cell adhesion and subsequent cell
growth (Fonner et al., 2008; Fahlgren et al., 2015; Guimard et al., 2007). Fonner et al.
(2008) showed PPy doped with chloride, tosylate, polystyrene sulfonate all had various
impacts on the final material properties. Chloride increased PPy roughness, tosylate
increased PPy conductivity and both tosylate and polystyrene sulfonate increased
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PPy cell adhesion when compared against each other. Given the biologic activity and
conductivity of PPy many researchers have begun using it in biomedical applications.
Vijayavenkataraman et al. (2019) used PPy combined with the co-polymer polycaprolactone to allow the 3D printing of porous nerve guide conduit with a max conductivity
of 1.15 mS/cm and allowed the differentiation of neural crest stem cells. Two types
of surface morphologies of PPy coating on titanium bone implants were investigated
to visualize the impact of osteoblast cell adhesion, proliferation and differentiation (He
et al., 2017). The rough surface of the PPy nanowire coatings supported increased
osteoconductivity compared to traditional PPy surfaces and titanium (He et al., 2017).
Additionally, electrical stimulation was applied to each of the substrates which yielded 2⇥
higher proliferation activity and increased the expression and secretion of proteins when
compared against no electrical stimulation (He et al., 2017). Electrical stimulation has
been shown to increase bone healing and mineralization in multiple studies (Brighton
et al., 1992; Wiesmann et al., 2001; Meng et al., 2013). Combining the conductive
nature of PPy and applying electrical stimulation to increase cell activity is a natural
advantage of this material. Yang et al. (2016) used PPy with hyaluronic acid hydrogels
to create highly conductive hydrogels for broad tissue engineering applications.
PPy has also been used as a biosensing and drug delivery platform for various
molecules in-vivo (Geetha et al., 2006). A redox reaction of the charged polymer allows
positive, neutral and negatively charges molecules to become entrapped into, or repelled
from, the CP (Tandon et al., 2017). Zanjanizadeh Ezazi et al. (2018) utilized mesoporous
PPy/silica scaffolds as a delivery system for vancomycin, specifically looking at bone
regeneration. The incorporation of PPy in the scaffolds allowed an increased dopant
release of 80%, compared to scaffolds without PPy which only achieved 50% dopant
release. As opposed to passive diffusion, there are methods of drug entrapment and
release that are more controlled, such as electrical or pH-triggered release (Shah et al.,
2018; Samanta et al., 2015). Electrochemical PPy dopant storage and release is based
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on a redox reaction that occurs when a voltage is applied (Wadhwa et al., 2006). Shah
et al. (2018) compared the release of dexamethasone phosphate and meropenem from
PPy films and highlighted an increase of 10–15% and 10–30% compared to passive
drug diffusion at each time point from electrical stimulation release using 30 s on at
0.6 V (a reducing potential). Hosseini-Nassab et al. (2016) showed the use of PPy
NPs that were doped with insulin with an on-demand release by applying 1 V for a
2 min pulse. With each subsequent pulse, the release of insulin increased in a stepwise manner. Wadhwa et al. (2006) used PPy coatings that were doped and undoped
with dexamethasone using cyclic voltammetry. After 1 release cycle 0.5 µg/cm2 was
achieved, totalling 16 µg/cm2 after 30 cycles, showing the very controlled means of
release using electrical methods. Although electrical release is useful, these controlled
voltages are not seen inside the human body and require external stimuli, leading to the
investigation of other stimuli methods. pH-sensitive release for PPy has been described
by Samanta et al. (2015) using PPy NPs doped with fluorescein, rhodamine-6G and
piroxicam. This author entrapped the drug molecules during PPy polymerization and
triggered release using various pH solutions. Drug release from the NPs showed that
negatively charged molecules (fluorescein and piroxicam) favoured release at pH 7.4 and
8 compared to pH 2 and 5. This was validated by Liubchak et al. (2020) with fluorescein
release from electrochemically doped PPy films showing a marked increase in release
at alkaline pH values. Samanta et al. (2015) described the process of dopant release
as a mixture of both electrostatic and hydrophobic interactions and that the higher pH
causes PPy deprotonation, therefore lowering the overall positive PPy backbone charge
and allowing the release of charged molecules. Given this literature, there is interest
in using PPy as an in-vivo drug delivery vehicle that can respond to changes in pH in
conjugation with hydrogels.
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Additive Manufacturing
Classifications

Additive Manufacturing (AM), otherwise known as 3D printing, is an emerging and
exciting creation methodology with a wide variety of applications. It uses computerassisted design (CAD) models and allows them to be turned into fully realized objects
through the layer-by-layer deposition of material. There are many classifications of
AM but they can be broken down into four main categories: extrusion-based, laserassisted, inkjet, and stereolithography, each offering specific advantages (Unagolla and
Jayasuriya, 2020). Briefly, extrusion-based 3D printing is a low-cost technique that most
individuals think of when considering 3D printing. It involves creating a structure from the
bottom-up where the material is being forced out of a nozzle through heating or pressure
gradients (Vaezi et al., 2018; Unagolla and Jayasuriya, 2020). Extrusion-based printing
is seen as simple and cost-effective but comes with a slow print speed and limitation
of resolution based on nozzle diameter (Murphy and Atala, 2014). Laser-assisted
3D printing used a two-layer setup where a laser is focused on the upper absorbing
substrate and the lower substrate acts as the collector, slowly building the print with
each laser pulse. This method offers microscale resolution but with a trade-off of high
price and preparation time (Murphy and Atala, 2014; Unagolla and Jayasuriya, 2020).
Inkjet printing offers a fast printing time through an aerosol-based system that forces
material droplets out of the nozzle onto a substrate to build up the print (Murphy and
Atala, 2014). Finally, stereolithography falls into the category of vat-polymerization. This
method uses liquid resins that can be solidified with UV light patterns projected onto the
surface of the resin, curing one thin layer at a time, seen in Figure 2.4 (FormLabs, 2021;
Cullen, 2018). AM, specifically looking at stereolithography, offers a very high resolution
with a fast printing time (Murphy and Atala, 2014; Unagolla and Jayasuriya, 2020).
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Figure 2.4: The process diagram for the stereolithography additive manufacturing
highlighting the repetitive process of (a) curing a thin polymer layer, (b) measuring the
height to the resin surface, (c & d) lowering the build plate to expose a fresh layer of
uncured resin, (e) measuring distance to resin surface and finally, (f) preparing for the
next layer cure (© Cullen and Price (2019), included with permission).
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Applications

Given that there are major limitations to the creation methodology and vast applications
for CPs, the OMASML group has worked to investigate the use of AM with CPs. Cullen
(2018) researched 3D printed PPy/Urethane Dimethacrylate and PPy/bisphenol A
ethoxylate dimethacrylate resins using stereolithography techniques and was able to
create complex 3D shapes, typically unachievable with traditional creation methods for
CPs. Holness (2017) combined polyaniline with dodecylbenzenesulfonic acid into a
paste for extrusion-based 3D printing applications and was able to achieve customizable
polyaniline shapes and patterns with a layer thickness of 200 µm and an XY resolution
of approximately 2 mm.
Bioprinting involves applying the previously outlined additive manufacturing techniques with living cells and biologic, growth and differentiation factors for the creation of
tissue engineering applications (Unagolla and Jayasuriya, 2020). The biologic applications of 3D printing are wide, ranging from 3D printed corneas to allowing surgeons to
better prepare for complex surgeries (Isaacson et al., 2018; Shilo et al., 2018). In Tissue
Engineering (TE), the creation of complex structures that match the physical, mechanical
and physiological properties of native tissues is often difficult due to inflexible processing
methods (Vaezi et al., 2018). Bioprinting is a customizable method that can involve
patient imagining, material selection, cell selection, printing and application, each step
allowing a range of choices and customizations to better model living tissue to ensure
biomimicry (Murphy and Atala, 2014). Kang et al. (2016) demonstrated the capabilities
of an “integrated tissue–organ printer” printing biodegradable polymers in conjunction
with cell-laden hydrogels using extrusion based methods. Cristovão et al. (2019) showed
the capabilities of extrusion based 3D printing tracheal implants design. Nguyen et al.
(2013) showed the use of a two-photon stereolithography printer for the creation of cell
scaffolds. Many applications of 3D bioprinting implement a hydrogel formulation due to
their cell-compatibility and ease of crosslinking (Unagolla and Jayasuriya, 2020). Addi-
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tionally, the previously outlined methods of AM CPs has been applied to bioprinting. Ma
et al. (2019) used PPy NPs paired with extrusion based 3D printing to create structures
that better match complex tissue types. Vijayavenkataraman et al. (2019) used PPy and
collagen for neural tissue devices but also used extrusion based 3D printing methods.
Li et al. (2018) successfully used extrusion based 3D printing to create poly-lactic acid
PPy scaffolds for bone regeneration with hydroxyapatite particles and dexamethasone
delivery. Stereolithography printing of CPs for biomedical applications has yet to be
researched and is the basis of this thesis.

2.4

Chapter summary

This chapter has outlined the necessary information pertaining to the research completed
in the following chapters. It has covered three key aspects to this project: bone, polymers
and AM. Specifically, the physiological characteristics of both bone and bone graft allow
the visualization of the tissue that is most important to this thesis. Polymers, highlighting
both hydrogels and conjugated polymers, along with the current research in each field
was presented. Finally, the various types of AM were explored with an emphasis on
bioprinting.
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Chapter 3
Development and Characterization of
Polypyrrole and Poly(ethylene) Glycol
Copolymer Resin Blend
This chapter outlines the process of creating a PPy/PEGDA photoactive resin blend.
PPy NPs were created through oxidative polymerization and incorporated into PEGDA
resin to form a composite biomaterial. Characterization of the photo-initiated resin was
completed before moving to Chapter 4: PPy/PEGDA Composite Resin Application.

3.1

Introduction

Traditional PPy synthesis methods are limited and lead to polymers with poor processability (Wang et al., 2001). This has hindered the use of PPy in applications that require
flexibility, such as 3D printing. One method of overcoming these poor material properties
is by combining PPy with a second polymer which offers complimentary characteristics. This two-polymer composition was the basis of the following experiments. The
goal of this chapter relates to the first objective of developing a biocompatible PPy
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resin that was capable of being printed on a UV-based stereolithography 3D printer.
This overarching goal extended between the material selection, creation and processing aspects of this chapter to ensure that steps were taken so the material would be
successfully 3D printed while having low cytotoxicity. To achieve this, PPy NPs were
incorporated into UV-curable PEGDA hydrogels with a natural photoinitiator, riboflavin.
PPy NPs offered a high surface-area-to-volume ratio, potential drug delivery ability and
electrical conductivity whereas hydrogels provided a customizable 3D polymer with high
biocompatibility and easily crosslinked through various methods (Samanta et al., 2015;
Unagolla and Jayasuriya, 2020). Previous works have studied PPy NPs and/or hydrogels
alone, no researchers have worked to characterize a composite PPy/PEGDA material.
To understand the composite PPy/PEGDA material, studies into PPy NPs, PEGDA
hydrogel matrices and the interaction between these two materials were completed
through UV-absorption, cure tests, swelling ratio studies and conductivity measurements.
The results of these tests showed a successfully cured PPy/PEGDA biomaterial using
riboflavin. Characterization of this bio-composite helped elucidate the interaction of
the two distinct materials, the hydrogel and the NPs. The composite material showed
a decreased swelling ratio and increased conductivity with each addition of PPy NPs,
to a maximum of 0.75% PPy. Above this limit, the NPs inhibited proper excitation of
the riboflavin molecule and the polymers were unable to cure. The following work has
successfully created a flexible biomaterial that harnesses the benefits of PPy within a
customizable PEGDA hydrogel format.

3.2
3.2.1

Materials and Methods
Materials

Pyrrole (CAS #109-97-7) was distilled prior to use to remove any impurities. Hydrochloric
acid (HCl) (CAS #7647-01-0) was diluted to 40 mmol/l with deionized H2 O. Sodium do-

C HAPTER 3. PP Y /PEGDA C OMPOSITE R ESIN C REATION

36

decyl sulfate (SDS) (CAS #151-21-3), PEGDA (Mn=700, CAS #26570-48-9), riboflavin
(CAS #83-88-5), TEA (CAS #102-71-6), Irgacure 2959 (CAS #106797-53-9), 30% hydrogen peroxide (H2 O2 ) (CAS #7722-84-1), Isopropyl alcohol (IPA) (CAS # 67-63-0)
and phosphate-buffered saline (PBS) (Fisher Cat. #10010023, 144 mg/ml Potassium
Phosphate monobasic, 9000 mg/ml Sodium Chloride, 795 mg/ml Sodium Phosphate
dibasic) were all used as received. 3.5K MWCO dialysis tubing was purchased from
ThermoFisher (Cat. #88242) and 3K NMWL Ultra-15 centrifugal filter units were purchased from Millipore Sigma (Cat. #UFC900308).

3.2.2

Methods

PPy NPs were created by dissolving 144 mg of SDS in 5 ml of 40 mmol/l HCl, stirred
at 200 r/min in a 20 ml beaker with a 2 cm egg-shaped stir bar on a magnetic hot
plate. After the SDS was dissolved, the rotational speed was increased to 1200 r/min
and 1 ml of distilled pyrrole was added in a drop-wise manner. Immediately after the
addition of pyrrole, 2 ml of 30% H2 O2 was added in a drop-wise manner. The mixture
was left for 24 h at 1200 r/min to completely polymerize. The solution was moved
into a pre-soaked 3.5K MWCO dialysis bag that was placed in 1 l of deionized H2 O.
The H2 O was changed every 24 h for 5 d. After the wash period, the solution was
sonicated for 1 h in a bath sonicator to break up any agglomerated NPs. Concentration
measurements were completed using evaporation in triplicate, measuring the beaker
mass before and after evaporation of 100 µl of solution to calculate the mass of PPy /ml.
NP size was measured by diluting 100 µl of NP solution in 10 ml of deionized H2 O and
placing the solution into a 90Plus/BI-MAS Zeta particle sizing machine which measured
10⇥/sample. From the Zeta sizing machine, the mean diameter and polydispersity
were averaged over 10 runs for each sample was collected. Particle morphology was
analyzed by evaporating a small sample of the washed PPy NP suspension on a glass
slide. A Keyence VHX-7000 optical microscope was used to visualize NP morphology
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on a micro-scale. Scanning electron microscopy (SEM) was used to visualize the
nano-scale of the PPy NPs. Silicon wafers were coated with iridium before pipetting the
NP solution on top. The samples were dried fully before being imaged using a Hitachi
SU8230 SEM with a 5 kV accelerating voltage and secondary electron mode. Polymers
were left uncoated during SEM to not obstruct the PPy NP surface morphology.
A 0.01 mg/ml Irgacure 2959 solution and 0.11 mg/ml riboflavin solution were created and read using a Cary 60 UV-vis spectrophotometer, the absorbance between
200

550 nm was collected. PEGDA resins were created using a 1:1 PEGDA:H2 O

ratio (described by Nguyen et al. (2013)) with varying concentrations of TEA. Six resins
with the following ratios of PEGDA:TEA were used: 36:1, 28:1, 20:1, 12:1, 4:1 and 3.2:1.
Riboflavin concentration was kept constant throughout these tests to ensure there were
no confounding variable effects. The maximum concentration of riboflavin was added
based off the solubility of 0.3 g/l of H2 O (Sigma-Aldrich, 2021). For each test resin, 5 ml
of PEGDA was combined with 5 ml of H2 O and 1.5 mg of riboflavin. The mixture was
sonicated to allow the riboflavin to fully dissolve. After dissolution, the desired amount of
TEA was added and the resin was vortexed. All resins were protected from light before
curing to prevent photobleaching. Absorbance was measured by diluting 1 ml of resin
with 10 ml of H2 O. Samples were read using a Cary 60 UV-vis spectrophotometer and
the absorbance between 300

500 nm was collected.

PPy resins were created using a 1:1 PEGDA:H2 O and 12:1 PEGDA:TEA ratio. Five
concentrations of NP solution were created 0, 0.1, 0.25, 0.5 and 0.75 wt%. PPy resins
will be referred to as the wt% of the NP solution used for creation here on in. Based
off the g PPy /ml measurements, solutions were either diluted or placed into a 3K
NMWL Ultra-15 centrifugal filter unit for 20 min at 3,270 (xg) RCF using an Allegra
X-12R centrifuge to concentrate the particles. Once the correct wt% were created,
5 ml of the PPy solution was added to 5 ml of PEGDA with 1.5 mg of riboflavin and
42 µl of TEA. The resin was sonicated and protected from light before testing. An
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identical UV absorbance preparation and collection process was followed for the PPy
resins compared to the TEA resins. To complete the swelling ratio tests, 160 µl of resin
was pipetted into 1 cm ⇥ 1.5 cm transparent polydimethylsiloxane molds in triplicate.
Polymers were cured using a 400 nm Prusa CW1. The 0, 0.1, 0.25, 0.5 and 0.75 PPy
resins were cured for 30, 40, 50, 60 and 60 min, respectively to obtain a solid polymer.
Each polymer was rinsed in IPA after printing to wash away the uncured monomers and
left to dry. Once dry, the polymers were weighed and placed into H2 O for 24 h. After
swelling, any excess water from the surface was absorbed with a paper towel and the
mass was recoded again. The swelling ratio was calculated using the following equation:

Swelling Ratio =

ms

md

(3.1)

md

where ms was the mass of the swollen polymer and md was the mass of the rinsed and
dried polymer before swelling. In addition to swelling ratio, the average molecular weight
between crosslinks, Mc , of the polymers were calculated using the following parameters
and formulas (Lin and Metters, 2006; Lin et al., 2011):
1
MC

=

2

v̄ /V1

Mn

⇥

ln (1

v2,r

⇣

v2, s ) + v2, s +
v2,s
v2,r

⌘ 1/ 3

v2,s
2v2,r

2
1 v2, s

⇤

(3.2)

where Mn was the average weight of the PEGDA (700 Mn), v̄ was the specific volume
of PEGDA (0.893 cm3 /g), V1 was the molar volume of water (18 cm3 /mol),

1

was the

Flory-Huggin’s PEG-water interaction parameter (0.426), v2,r was the polymer fraction
(0.5 for this resin composition) and v2,s was the polymer volume fraction in the swollen
state, defined by the following formula:

v2,s =

1
⇢2
Qm

⇢1

+

1
⇢2

(3.3)
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where ⇢1 and ⇢2 was the density of the solvent and PEGDA respectively and Qm was
the mass swollen ratio. Equation 3.2 is a modified version of the Flory-Rehner model,
described by Peppas and Merrill where polymerization occurred while in H2 O (Peppas
and Merrill, 1977; Lin and Metters, 2006; Lin et al., 2011).
Conductivity was measured using a 4-point probe method, with electrodes placed
2 mm apart, on both dry and PBS-swollen polymers. Conductivity was recorded with a
Keithley 2611 source meter combined with a custom Matlab script. Voltage measurements were taken until a stable reading was achieved and the average over 25 s was
used in the following equation to calculate conductivity:

=

where

I ⇤ ln 2
⇡⇤ V ⇤t

(3.4)

is the apparent conductivity, I is the current applied between the first and fourth

electrodes,

V is the recorded voltage drop between the second and third electrodes

and t is thickness. It should be noted that a correction divisor to account for thickness
was incorporated into this calculation, defined by Blythe (1984), due to the polymers
having significantly different thicknesses depending on the PPy concentration used.
Results are reported alongside the standard error (SE), n=3 unless otherwise stated.

3.3
3.3.1

Results
Nanoparticle Creation and Characterization

PPy NP sizing was averaged over three polymerization reactions and showed a mean
diameter of 72.5 ± 7.5 nm and a polydispersity of 0.122 ± 0.038. The size distribution
data of each run was collected from the Zeta software which uses a Non-Negatively
constrained Least Squares algorithm to fit the data, seen in panel (a) of Figure 3.1.
The three runs of n = 1, 2 and 3 had an average particle diameter of 70.5, 86.4
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and 60.7 nm respectively. SEM, seen in panels (b) and (c) of Figure 3.1, show the
creation of NP through the polymerization process. Both panels (b) and (c) showed
spherical PPy NPs with some irregularities and a rough surface topography. The
diameter measurements in panel (c) showed a range of diameters between 39.4 to
157 nm, averaging 73.8 ± 11.2 nm.

3.3.2

PPy/PEGDA Resin Creation and Characterization

The absorbance plots in Figure 3.2 showed the peaks of riboflavin at 370 nm and
444 nm compared to a commercially available photoinitiator, Irgacure 2959, with a single
peak at 276 nm. The Irgacure 2959 photoinitiator was shown to be ineffective at the
wavelength of the OMASML printer whereas riboflavin had a relatively high absorbance.
The UV absorption from each TEA ratio resin, seen in Figure 3.3, showed variable peak
absorbances. The specific peaks of each curve were in the same locations, fitting the
Riboflavin UV absorption curve seen in Figure 3.2. It was observed that three ratios of
28:1, 20:1 and 12:1, were grouped together and had increased absorption compared
to the three other resins. The largest (36:1) and smallest (4:1, 3.2:1) TEA ratio resins
yielded the lowest absorption values at all wavelengths. At 385 nm, the 20:1 and 12:1
samples showed the highest absorption.
After characterization of the PEGDA resin by itself, PPy NPs were added. The UV
absorbance of each PPy concentration resin, outlined in Figure 3.4, was collected and
showed the impact of the black PPy NPs. With each increase in the concentration of
PPy NPs, the UV absorption of the diluted resin was also increased. The 0 PPy resin
served as a baseline with no interference from the PPy NPs, highlighting the same
riboflavin peaks seen in Figure 3.2 and Figure 3.3. The specific peak at 370 nm was
less distinct in the samples with larger concentrations of PPy, with a total loss of the
absorbance peak seen with the 0.75 PPy resin.
PPy/PEGDA resins were cured for variable lengths of time with the Prusa SL1 due to
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(a)

(b)

(c)

Figure 3.1: Polypyrrole (PPy) nanoparticle sizing and morphology results: (a) size
distribution of three separate creation trials showing the variance in average diameter
between trials, (b) SEM images of the nanoparticles and (c) measured SEM images
outlining the size distribution seen in panel (a).
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Figure 3.2:
The UV absorption spectrums for 0.01 mg/ml Irgacure 2959 and
0.11 mg/ml riboflavin in H2 O, showing the riboflavin peaks are very close to the emission wavelength of the OMASML printer whereas Irgacure 2959 peaks occur at 270 nm
and is barely excited at the printer emission wavelength, ruling it out of this application.
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Figure 3.3: UV absorption of diluted poly(ethylene) glycol diacrylate (PEGDA) and
triethanolamine (TEA) and riboflavin resins with the following ratios (PEGDA:TEA): 36:1,
28:1, 20:1, 12:1, 4:1 and 3.2:1, based off research from Nguyen et al. (2013) and
Cristovão et al. (2019).

Figure 3.4: UV absorption of diluted poly(ethylene) glycol, riboflavin, triethanolamine
and polypyrrole (PPy) nanoparticle (NP) suspension (0, 0.1, 0.25, 0.5 and 0.75 wt%)
resins. The absorption increases as the black PPy NPs are added, as they decrease
the amount of light able to pass through the samples. The loss of the 370 nm riboflavin
peak was observed in the 0.75 PPy sample.
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(d)

(e)

Figure 3.5: Cast polypyrrole (PPy) and poly(ethylene) glycol diacrylate resins, created
with (a) 0, (b) 0.1, (c) 0.25, (d) 0.5 and (e) 0.75 wt% PPy H2 O suspensions cured for 30,
40, 50, 60 and 60 min, respectively, showing the dramatic change in colour and surface
roughness that the particles had on the final hydrogel composition.
the higher UV absorbance seen in Figure 3.4, yielding the polymers seen in Figure 3.5.
The 0, 0.1, 0.25, 0.5 and 0.75 PPy polymers were cured for 30, 40, 50, 60 and 60 min
respectively, to ensure that there was solidification throughout the entire depth of the
polymer. Panel (a) shows the colour of the print due to the yellow-riboflavin molecule.
Both the 0 and 0.1 PPy polymers were still semi-transparent after curing whereas the
0.25, 0.5 and 0.75 PPy polymers were deep black. The 0.75 PPy polymer was cured for
60 min and only a thin film was cured, seen in Panel (e), highlighting the inefficiency of
the photoinitiation system with added PPy NPs.
Results from the PPy/PEGDA polymer swelling ratio and Mc calculations showed
that the incorporation of PPy NPs into the hydrogel modified the PEGDA crosslinking.
Figure 3.6 showed that with each increase in PPy NP concentration, there was an
observed decrease in swelling ratio. The 0.75 PPy sample showed the lowest swelling
ratio of 0.18 ± 0.03. The 0.1, 0.25 and 0.5 PPy polymers showed a swelling ratio of
0.92 ± 0.08, 0.63 ± 0.08 and 0.73 ± 0.07. Only the 0 PPy sample showed a swelling
ratio larger than one, with a ratio of 1.37 ± 0.12. Using Equation 3.2 and Equation 3.3,
the average molecular weights between chains were calculated. The 0, 0.1, 0.25 and
0.5 PPy samples all showed similar results, having Mc values of 546 ± 16, 630 ± 22,
747 ± 40 and 699 ± 30 g/mol respectively. The 0.75 PPy sample had a very high Mc
value of 1400 ± 123 g/mol.
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Figure 3.6: Swelling ratio of the polypyrrole (PPy) and poly(ethylene) glycol diacrylate
resins, showing the impact of the addition of PPy nanoparticles on the matrix.
Conductivity measurements of both the dry and PBS-swollen PPy/PEGDA polymers
were outlined in Figure 3.7. The conductivity of the dried polymers showed that there
was a large increase in conductivity for all PPy hydrogels compared to the PEGDA hydrogel alone, which had a conductivity of (2.2 ± 0.03) ⇥ 10

8

S/cm. The 0.1, 0.25 and

0.5 PPy polymers yielded conductivity values of (1.6 ± 0.13) ⇥ 10 7 , (1.5 ± 0.13) ⇥ 10
and (2.5 ± 0.28) ⇥ 10

7

7

S/cm respectively, showing a 6.8 to 10⇥ increase in conductiv-

ity compared to PEGDA alone. The 0.75 PPy polymers yielded the highest conductivity
of (5.6 ± 0.97) ⇥ 10

7

S/cm, a 25-fold increase compared to 0 PPy polymers. ANOVA

testing showed that there was a significant difference (p < 0.05) between all samples
and the 0.75 PPy polymer. The PBS swollen samples all yielded higher conductivity
values compared to the dry samples, shown in Figure 3.7 panel (b). The 0 PPy polymer
yielded a conductivity value of 2.1 ± 0.4 mS/cm. Interesting, 0.1 PPy polymer showed
the lowest conductivity of 1.2 ± 0.2 mS/cm. The 0.25 and 0.5 PPy samples gave conductivity values of 2.5 ± 0.2 and 2.1 ± 0.1 mS/cm respectively. Finally, the 0.75 PPy
sample showed the highest conductivity of 3.5 ± 1.0 mS/cm. ANOVA testing with a p
values of 0.05 showed a significant difference in conductivity between the 0.1 and 0.75
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(b)

Figure 3.7: Conductivity measurements of polypyrrole (PPy) and poly(ethylene) glycol
diacrylate resins when (a) dry and (b) swollen in phosphate buffered saline, showing
increase in conductivity due to the addition of conductive PPy nanoparticles.
PPy samples (p = 0.013).

3.4
3.4.1

Discussion
Nanoparticle Creation and Characterization

NPs were created using oxidative chemical synthesis, outlined in Figure 3.8. The process used SDS to suspend micelles of pyrrole monomers in an acidic medium. This
type of pyrrole polymerization method has been previously described by Samanta et al.
(2015) and Leonavicius et al. (2011) and was chosen as it avoids the use of harsh
oxidization conditions or oxidizing agents. This polymerization method avoids the use of
FeCl3 , K2 Cr2 O and KMnO4 etc. which are strong oxidizing agents that have the potential
of being incorporated into PPy NPs and cause downstream effects, such as cytotoxicity (Leonavicius et al., 2011). As these NPs were used in biomedical applications, a
H2 O2 polymerization process was implemented. The success of polymerization was first
visualized by the colour change of the solution, demonstrated in Figure 4.4. The mixture
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started as a cloudy white pyrrole suspension just before adding H2 O2 and immediately
darkened after the addition of H2 O2 . After 24 h, the solution was completely black,
indicating the complete polymerization of pyrrole. Leonavicius et al. (2011) described
the micelle size of 20

30 nm which correlated to the 30 nm diameter particles created.

The average diameter of the particles created in this thesis was 72.5 ± 7.5 nm, slightly
larger compared to Leonavicius et al. (2011). The SEM images seen in Figure 3.1
validated the ZETA measurements and showed that some micelles were able to achieve
the 40

50 nm range. Samanta et al. (2015) created PPy NPs with 34, 43 and 28 nm

diameter with fluorescein, Piroxicam and rhodamine-6G incorporated into the polymerization solution. The larger diameter particles in this study are most likely due to the
10⇥ increase in PPy and H2 O2 volumes compared to Samanta et al. (2015) during
polymerization, creating larger pyrrole micelles. The 10⇥ volume increase allowed for
increasingly concentrated NP solutions to be created, used in the PPy/PEGDA resins.
Additionally, Leonavicius et al. (2011) used a rotational speed of 2,500 r/minwith unspecified equipment sizes (beaker and stir bar) whereas this study was limited by the
equipment available which had a maximum of 1,200 r/min, these changes may affect
emulsification conditions and micelle size. Referencing other types of oxidants, the
H2 O2 polymerization method yielded comparable NPs. For example, Wen et al. (2017)
used FeCl3 to create PPy NPs 86.8 nm in diameter. Kwon et al. (2008) also used FeCl3
with various surfactants to create cubed PPy NPs with diameters between 60

100 nm.

The results of this study showed the success of creating PPy NPs that could then be
used for biomedical applications, although yielding a larger diameter than Samanta
et al. (2015) and Leonavicius et al. (2011), the particles were still on the nano-scale.
The large variance between n-values, seen in Figure 3.1, is hypothesized to be from
minor differences in the creation process that could not be accounted for, such as minor
differences in speed of H2 O2 addition and vortex quality, that could affect the particle
diameter by changing the micelle size. Overall, this method successfully created PPy
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Figure 3.8: Diagram outlining the oxidative polymerization process of PPy (© Wang
(2016), included with permission).
NPs that could then be incorporated into PEGDA resins.

3.4.2

PPy/PEGDA Resin Creation and Characterization

Figure 3.2 demonstrated the UV absorbance of riboflavin and Irgacure 2959. Irgacure
2959 is semi-biocompatible, commercially available photoinitiator that is commonly
used due to its efficiency (Williams et al., 2005). Although said to be biocompatible, at
larger concentrations or with certain cell lines Irgacure 2959 has been deemed to be
cytotoxic (Williams et al., 2005). Additionally, the absorption curve shows that significant
excitation doesn’t occur above 365 nm, making it an ineffective photoinitiator for the
OMASML printer. The UV absorbance of riboflavin showed the molecule is excited
at 385 nm light emitted by the OMASML printer, making it an optimal biocompatible
choice. Riboflavin has previously been used as a photoinitiator, Orellana et al. (1999)
first investigated its use in conjunction with TEA to polymerize vinyl. Referencing
pertinent literature on riboflavin and TEA photoinitiation, two studies using riboflavin/TEA
for the polymerization of PEGDA were chosen to base the TEA concentration tests
on. Cristovão et al. (2019) used this polymerization method with extrusion based
3D printing with a PEGDA:TEA ratio of 3.2:1 and Nguyen et al. (2013) used a 36:1
PEGDA:TEA ratio with two-photon 3D printing using high-powered lasers. From this

C HAPTER 3. PP Y /PEGDA C OMPOSITE R ESIN C REATION

49

literature, a range of PEGDA:TEA ratios were chosen to optimize the concentration for
the OMASML printer. A linear trend in absorbance was expected as the amount of TEA
was increased. Surprisingly, it was shown that the 12:1, 20:1 and 28:1 ratios had the
highest UV absorbance values compared to the 3.2:1, 4:1 and 36:1 ratios. Orellana
et al. (1999) outlined that amine concentration to create active radicals was not linear.
The graphs of both Polymerization Rate and Active Radical Yield vs. TEA Concentration
showed a sharp increase in Polymerization Rate and Active Radical Yield with TEA
concentration until peaking at 0.01 mol/l, then slowly decreasing. Although this study
used HEMA/water at a (1:2) (v/v) ratio at pH 9, the same trend of TEA concentration
was seen. It was noted that during the curing process for the TEA resins, the higher
ratios of PEGDA:TEA were quickly photo-bleached, leading to a clear polymer. This
observation was important as the incorporation of NPs severely inhibited riboflavin
excitation (discussed below), leading to a smaller ratio of PEGDA:TEA being chosen.
The final PEGDA:TEA ratio was chosen to be 12:1, which contained a significant
concentration of TEA to keep riboflavin excited without photobleaching.
The addition of PPy NPs was shown to greatly affect the PEGDA matrix that was
formed. Figure 3.4 showed that the UV absorbance of the resins increased with
the larger concentrations of PPy NP. This is due to the black PPy NPs absorbing an
increasing amount of UV light and blocking the riboflavin molecules from becoming
excited. Although it has been shown that the absorbance of PPy NPs is low between
300–600 nm and some visible light can pass through, Figure 3.4 showed a concentration
dependent absorbance (Chen et al., 2015). These absorption results fit with the polymercure times that were used to create Figure 3.5. With each addition of PPy, a longer cure
time was required to solidify the mixture, again showing that an increased amount of light
was being absorbed by the PPy NPs. The 0.75 PPy resin was cured for the longest and
the polymer created was incredibly thin, showing that 0.5 PPy was the maximum PPy
concentration that could be incorporated into the resin. Other research incorporating
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NPs showed various impacts on the hydrogel creation and properties. Ma et al. (2019)
created poly-l-lactide scaffolds with 0.5% (w/v) PPy particles but avoided the issues
with curing by implementing an extrusion based 3D printing method. Lee et al. (2018)
used similar stereolithography methods to print PEGDA resin with 0.02–0.1% (w/v)
black carbon nanotubes but did not discuss curing issues with larger concentrations.
Interestingly, Fantino et al. (2018) avoided the use of NPs by implementing a two-step
polymerization process where PEGDA was first created with stereolithography and a
subsequent interfacial polymerization method deposited PPy on the surface on the
hydrogel. Looking into the hydrogel matrix properties, it was seen that the addition of
PPy NPs impacted the hydrogel quality. Swelling ratio studies showed that the addition
of PPy NPs lowered the water absorption. Swelling ratio is defined as water absorptivity
of the polymer and can be modified through the crosslinking density. Polymers with
closer crosslinks are able to expand less. This has been seen with higher molecular
weight PEGs having larger mesh sizes and swelling ratios compared to PEG with lower
molecular weights (Park et al., 2009). The results from the addition of the PPy NPs
into PEGDA resin show the opposite phenomenon, smaller swelling ratios as the PPy
concentration was increased. It was hypothesized that the addition of PPy would allow
larger spaces between crosslinks, therefore increasing the swelling ratio. The average
molecular weight between PEGDA crosslinks was calculated to examine the degree
of crosslinking for each PPy concentration. Results from this study showed that the
0.75 PPy resin had a Mc twice the Mn value of PEGDA (700 Mn), whereas the 0–0.5
PPy resin showed an average Mc value between 546–747(g/mol). The high Mc value
and low swelling ratio of the 0.75 PPy polymer was hypothesized to be from excess
unreacted monomers that were not able to polymerize due to PPy NPs blocking the
riboflavin excitation. Looking at literature with hydrogel swelling and NPs, Sajesh et al.
(2013) described lower swelling ratios due to the addition of PPy-alginate into chitosan
polymers, stating that the PPy in that application was hydrophobic. A contact angle study
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of the PPy NPs created in this study could determine their interaction on the swelling
ratio. Chang et al. (2010) also saw a reduced swelling ratio with larger concentrations of
Laponite NPs in PEGDA hydrogels, attributing the decease to the interaction of Laponite
and PEG causing a higher cross-linking density. Further testing is needed to elucidate
the relationship between swelling ratio and PPy NP concentration. Overall, this study
showed that the maximum concentration of PPy NP solution that can be added into
a 1:1 PEGDA:H2 O resin was 0.5 wt.% before the addition severely affects the matrix
properties.
Finally, the conductivity of the scaffolds was collected as the incorporation of PPy
NPs was hypothesized to improve the electrical properties of the PEGDA hydrogels.
The conductivity of these scaffolds is important because bone has the capability to
respond to external electrical stimuli for improved healing (Sajesh et al., 2013; Wiesmann et al., 2001). Additionally, osteoblast differentiation has been shown to increase
in the presence of electrical stimuli (Liu et al., 2013). This means that conductive
PPy/PEGDA bone scaffolds could be electrically modulated after implantation to increase healing. The 4-point probe method implemented allowed the conductivity to be
measured without a dependency on the contact area (Blythe and Bloor, 2008). The
addition of PPy NPs showed a large increase in the conductivity values when the polymers were dry and swollen in PBS. The PBS samples had the compounding effect
of ionic conductivity from the ions present in solution, but allowed a physiologically
relevant testing environment. The 0.25 and 0.75 PPy PBS-swollen samples yielded
conductivity measurements higher than bone marrow (0.23 S/m), where the 0 and 0.5
PPy samples were just under this target (Balmer et al., 2018). All PBS-swollen polymers
showed a higher conductivity compared to cortical bone (9.1 mS/m) (Balmer et al.,
2018). Comparing these polymers to other conducting hydrogels, Guarino et al. (2013)
used a polyaniline/PEGDA polymer and were able to achieve conductivity values of
(1.1 ± 0.2) ⇥ 10

8

and (1.1 ± 0.5) ⇥ 10

6

S/cm for 1:99 and 3:97 PANI:PEGDA ratios,
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showing that the polymers in our study had higher conductivity values with smaller
concentrations of CP. Liang et al. (2018) used hyperbranched poly(amino ester)-pyrrole
with gelatin that was capable of in-situ polymerization that gave a maximum conductivity
of (6.51 ± 0.12) ⇥ 10

4

S/cm. This application used Fe+3 to polymerize pyrrole and

were not limited by the UV-absorbance described above. The conductivity measurements showed that these scaffolds can be applied in future studies in osteogenic healing
applications.

3.5

Chapter summary

This chapter has outlined the creation and characterization methodologies used to
develop a PPy/PEGDA resin. First, PPy NPs were created using oxidative polymerization
methods and subsequently characterized according to size and morphology. The
investigation into a non-cytotoxic photoinitation system for PEGDA led to the use of
riboflavin and TEA. Combining PPy NPs and photoactive PEGDA created a composite
hydrogel that was characterized through UV-absorbance, swelling-ratio and conductivity.
These tests have shown the success of creating a conductive photoactive resin that
can applied to varied applications, outlined in Chapter 4: PPy/PEGDA Composite Resin
Application.
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Chapter 4
PPy/PEGDA Composite Resin 3D
Printing and Drug Delivery
This chapter covers the applications of the PPy/PEGDA resin described in Chapter 3:
PPy/PEGDA Composite Resin Creation. The 3D printing capabilities of the resins were
characterized to determine the minimum feature resolution to ensure it can achieve the
pore sizes needed for osteogenesis. Additionally, the drug delivery capabilities of the
PPy NPs encapsulated in PEGDA resin were evaluated over a biologically relevant pH
range.

4.1

Introduction

Stereolithography printing technology, outlined in Chapter 2, allows the creation of
highly customized 3D shapes that are optimal for patient customized biomedical devices.
Previous studies have used extrusion based 3D printing with CP/hydrogel composites,
but were limited by the nozzle size and rheological properties of the printing ink (Vijayavenkataraman et al., 2019; Li et al., 2018). Given the development of the photoactive
PPy/PEGDA resin outlined in Chapter 3 and the advantages of stereolithography print-
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ing, characterization of the PPy/PEGDA resin 3D printing capabilities was seen as
the next step towards patient customized PPy/PEGDA devices. To our knowledge, no
study has combined PPy/PEGDA into a resin for stereolithography printing. Testing
was focused on the XY print resolution of the PPy/PEGDA resins, the minimum print
diameter for both positive and negative features allowed the impact of the PPy NPs on
the PEGDA print resolution to be characterized. The prints tested the stereolithography
parameters for the customized OMASML printer to create complex microarchitectures
that are needed for osteo-scaffolds for biomedical applications. The goal was to achieve
the smallest features possible, as that would set the lower limit for porosity moving
forward in research. Additional prints fabricated using 3D bone models obtained from
micro-CT imaging allowed validation of real world osteogenic applications in which these
implants could be used in place of traditional bone grafts. In addition to 3D printing, the
drug delivery capabilities from the PPy NPs was investigated. Previous studies have
shown that PPy is capable of dopant entrapment and release, outlined in Chapter 2. The
drug-delivery tests helped elucidate the dopant entrapment and release characteristics
from PPy NPs for their utilization in areas of bone regeneration. The goal of this section
was to maximize dopant entrapment, while protecting drug function, and show the pH
dependent release from NPs. Past literature tested pH-triggered dopant release from
PPy NPs over large pH ranges, whereas this study narrowed the pH release values to
a physiological range between 6 – 8 (Samanta et al., 2015). Both PPy NPs alone and
PEGDA encapsulated NPs showed pH triggered release, favouring larger release in
increasingly alkaline conditions. The experiments outlined below demonstrate both the
3D printing and drug delivery capabilities of the PPy/PEGDA resins.
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Materials and Methods
Materials

Fluorescein (FL) (CAS #2321-07-5) and vancomycin (CAS #1404-90-6) were used as
received. Three potassium phosphate monobasic/sodium hydroxide buffers of pH 6, 7 &
8 were mixed to create a pH range between 6–8 at 0.25 increments (CAS #SB104-500,
#SB108-500, #SB112-500, respectively). Pyrrole, HCl, SDS, H2 O2 , PEGDA, riboflavin,
TEA, IPA and PBS were all used as listed in Chapter 3.

4.2.2

Methods

To identify the effect of PPy NP concentration on feature resolution, four PPy/PEGDA
resins (0, 0.1, 0.25 and 0.5 PPy) were created as outlined in Chapter 3. Resins were
cured using the custom-designed OMASML digital light projection printer, outlined in
Figure 4.1. The printer had an emission wavelength of 385 nm, an irradiation energy
of 7.37 J/cm2 and a theoretical minimum XY feature resolution of 5 µm. PPy/PEGDA
resolution was measured using the patterns outlined in Figure 4.2, adapted from an
open access online repository, Thingiverse (Thingiverse #2011862). To create the print,
five layers of Figure 4.2 panel (a) was cured, followed by 5 layers of panel (b). All prints
used a 25 µm layer thickness and a 5 s settling time. The cure time for the 0, 0.1, 0.25
and 0.5 PPy resins was selected to be 1.5, 20, 100 and 200 s/ layer based off previous
printing results and the UV absorbance data in Chapter 3. Cured polymers were rinsed
with IPA to remove any excess resin. Images were collected using a Keyence VHX-7000
digital microscope. To validate material functionality for bone grafts, two resins (0 PPy
and 0.1 PPy) were selected to print a 50 layer micro-CT scan of trabecular bone, seen in
Figure 4.3, with identical parameters as above. These two resins were selected because
they had the shortest curing times, allowing rapid testing and evaluation of various
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(b)

Figure 4.1: Images of the custom designed stereolithography printer outlining (a) the
general overview, labelled with the important components, and (b) the light pattern being
projected on a layer of resin.
print parameters. The model was adapted from Thingiverse #3750517. Post-imaging
measurements were completed using ImageJ.
For drug delivery testing, PPy particles were created following the methods described in Section 3.2.2 with minor changes to incorporate dopant molecules. To create
FL-doped NPs, 30 mg of FL was added to the SDS and HCl mixture before pyrrole
polymerization, seen in Figure 4.4. FL-doped NPs were washed for 5 d following the
same procedure in Chapter 3 to wash away any unbound dopant molecules. To create
vancomycin doped NPs, 2.5 ml of washed un-doped PPy NPs were mixed with an equal
volume of 25 mg/ml vancomycin dissolved in distilled water. The solution was vortexed
for 10 min to attach vancomycin molecules on the surface of PPy NPs. The mixture was
placed into a 3K MWCO dialysis bag in 1 l of distilled water and left overnight to remove
any unbound vancomycin. After 12 h, a 10 ml sample of the wash fluid and the wash
liquid volume was collected to calculate drug loading.
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(b)

Figure 4.2: The (a) hole and (b) pillar pattern to create the hole/pillar test print where
everything shown in white is solidified. 5 layers of (a) were exposed followed by 5 layers
of (b) which created a measurable print that defined the smallest feature resolution of
various resin composition (All measurements in µm).

(a)

(b)

Figure 4.3: (a) The CAD model created from Micro-CT data from trabecular bone with
30% bone volume/tissue volume and (b) an example of one of the 50 layers in the print
pattern created from the CT model.
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Two conditions were used to measure drug release from PPy NPs between pH 6–8
at 0.25 increments. PPy NPs alone and PEGDA encapsulated PPy NPs were tested for
drug release. For NP release, 100 µl of doped-PPy NP solution was added to 3 ml of pH
solution in triplicate and incubated at 37 C. To create PEGDA encapsulated doped-NPs,
the resin formula described in Chapter 3 was used along with the same casting method.
The drug-doped PPy/PEGDA polymers were rinsed with IPA and subsequently placed
into buffer solutions at 37 C. FL-doped NP release was measured for over four time
points: 2 h, 24 h, 7 d and 14 d. FL has a pH dependent absorbance value, showing a
50% decrease in absorption at 490 nm between pH 7.5 to 6.75, therefore the isosbestic
value of 460 nm was selected to measure absorbance (Doughty, 2010). Vancomycin
doped NP release was measured at 2 h and 24 h. The peak for vancomycin were seen
at 281 nm and were used in conjunction with standard curves to calculate the dopant
release values. A Cary 60 UV spectrometer was used to collect the absorbance data
between 200 and 600 nm. Statistical analysis was completed using MATLAB. Results
are reported with the standard error (n=3) unless otherwise stated. Two-way (analysis
of variance) ANOVA was completed using a p value of 0.05.
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(a)

(b)
Figure 4.4: (a) Schematic of the polymerization of pyrrole micelles using hydrogen
peroxide to initiate oxidative polymerization and (b) the colour change seen during
pyrrole polymerization with incorporated fluorescein molecules at 1. before the addition
of pyrrole, 2. immediately following the addition of pyrrole, 3. 1 h after adding hydrogen
peroxide and 4. 24 h after the addition of hydrogen peroxide.
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Results
3D Printing

Resolution testing of the PPy/PEGDA resins was visualized through the polymers
created in Figure 4.5. The printing time of each resin was adjusted to allow for adequate curing and increased alongside PPy concentration, as described in Chapter 3:
PPy/PEGDA Composite Resin Creation. The layer cure time was increased in 30 s
intervals until solidification was seen. From this base, the print time was adjusted as
needed based on the print quality, looking at feature resolution and layer adhesion.
These tests were not seen as exhaustive as various print parameters such as cure time,
settling time, layer thickness and depth between layers could impact the resolution, this
study only focuses on layer print time. The minimum feature resolution measurements
along with the pattern diameters are outlined in Table 4.1. Table 4.2 outlines the error
between print pattern and the achieved print resolution, using a 150 µm pillar pattern
and a 200 µm hole pattern. These diameters were chosen because they were the
smallest diameter that all resins could achieve and could be compared. Overall, resins
with larger concentrations of PPy showed smaller diameter features with smaller pillar
resolution error and larger hole resolution error. The 0.5 PPy resin was able to achieve
the smallest diameter pillars and holes. The 0.5 PPy resin also showed the least amount
of over-cure, where excess resin is cured outside the given light pattern, outlined in
Table 4.2 with the smallest pillar error. The 0 PPy resin showed the most over-cure,
yielding the largest diameter pillar with the smallest print pattern and the largest pillar
error, with +147 µm larger diameter seen compared to the pattern. Bone prints, seen in
panel (e) and (f) of Figure 4.5, were successful in mimicking trabecular bone architecture.
The 0 PPy resin was able to print a wall thickness of 30 µm and a pore diameter of
119 µm. The 0.1 PPy resin yielded a minimum wall thickness of 42 µm and a minimum
pore diameter of 184 µm. Looking at the z-resolution, the theoretical total print height
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PPy
0
0.1
0.25
0.5

Pillar
Achieved (µm) Pattern (µm)
138
50
125
100
137
100
120
150

65

Hole
Achieved (µm) Pattern (µm)
114
250
105
350
72
200
73
200

Table 4.1: Minimum achieved pillar and hole diameter for polypyrrole/poly(ethylene)
glycol diacrylate resins, showing the smaller feature resolution possible due to the
increase in concentration of NPs.
PPy
0
0.1
0.25
0.5

Pillar
Achieved (150 µm)
297
192
188
120

Error (µm)
+147
+42
+38
-30

Hole
Achieved (200 µm)
135
104
91
99

Error (µm)
-65
-96
-109
-101

Table 4.2: Achieved pillar and hole diameter for polypyrrole/poly(ethylene) glycol
diacrylate resins using the 150 µm and 200 µm diameter pillar and hole patterns,
respectively, showing the change in printing resolution errer due to the increase in
concentration of NPs.
was 1250 µm and the 0 PPy and 0.1 PPy resins gave print heights of 1738 and 1555 µm
respectively. The bone prints showed higher than expected total print heights, most
likely due to the manual adjustment of the build plate during setup, which could lead to
variances in the first layer thicknesses.

4.3.2

PPy Drug Delivery

Figure 4.4 outlines the process that occurred during PPy polymerization to create FLdoped NPs, visualized by the colour change moving from yellow to dark black due to
the creation of PPy NPs. The UV absorption curve measurements seen in Figure 4.6
showed the peak of both dopant molecules. The FL molecule showed a peak at 488 µm
and the vancomycin molecule showed a distinct peak at 281 nm. FL release between
pH 6–8 at 0.25 increments was collected in triplicate over a 14 d period, shown in

C HAPTER 4. PP Y /PEGDA C OMPOSITE R ESIN A PPLICATION

(a)

(b)

(c)

(d)

(e)

(f)

66

Figure 4.5: Pillar and hole print resolution tests with (a) 0 PPy, (b) 0.1 PPy, (c) 0.25
PPy, and (d) 0.5 PPy resins. Trabecular bone micro-CT prints using (e) 0 PPy and (f)
0.1 PPy resin, showing the applicability of PPy/PEGDA resins.
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Figure 4.6: Absorption spectrums of both fluorescein (2.5 µg/ml) and vancomycin
(0.125 mg/ml) molecules, showing their respective peaks at 488 and 281 nm that were
used to detect drug release from the nanoparticles.
Figure 4.7. FL release was normalized by the mass of PPy NP used in each study. At all
time points there was an increase in the average FL release at higher pH values, seen
by the positive slope of all release graphs in panels (a) through (d). This qualitatively
demonstrated the pH-dependent release that PPy is capable of. The 2 h release data
showed overlapping averages when looking at the particle and resin FL release. This
was contrasted against the 24 h, 7 d and 14 d experiments where the resin yielded
higher averages values compared to the particles alone. The time dependent release
from PPy NPs was visualized in panel (e) of Figure 4.7, highlighting three pH values:
6, 7 and 8. It can be seen that there was increased FL release for both the 7 d and
14 d time points compared to the shorter release times. Two-way ANOVA testing was
completed measuring FL release between pH and release time for the NPs alone and
resin encapsulated NPs. NP FL release was statistically significant for pH (F=2.40,
p=0.0234) and for release time (F=5.16, p=0.0028). Specifically, there was a difference
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in release between pH 8 and 6, 6.25 and 6.75. The resin encapsulated NPs showed
no statistical differences in FL release by pH (F=0.42, p=0.9037) but the release was
significant for release time (F=21.44, p=4.99 ⇥ 10

10

).

Vancomycin showed a less pronounced release trend over the tested pH values,
seen in Figure 4.8. From the NP wash liquid, drug loading was calculated and taken as
100%. The vancomycin doped NPs were able to achieve an encapsulation efficiency
of 16% from the solution that they were vortexed in. Vancomycin release from NPs
alone was almost identical at both time points, yielding an average over all pH values of
50.7 ± 0.01 and 51.2 ± 0.02 % release for 2 and 24 h respectively. Slight decreases
in the cumulative release between 2 h and 24 h are due to the filtering process at the
24 h timepoint where an added 1 ml of H2 O was added to pre-wet the filter, but was
accounted for in the release calculations. In contrast, PEGDA encapsulated PPy NPs
showed an average release of 30.2 ± 0.01 % over 2 h and 63.0 ± 0.03 % over 24 h,
demonstrating the effect of encapsulating NPs into PEGDA. A two-way ANOVA was
used and showed that NPs alone did not have a significant difference between the pH or
release time and vancomycin release. PEGDA encapsulated vancomycin NPs showed
a statistically different release in regards to pH (F=2.22, p=0.049) and release time
(F=511.0, p=7.32 ⇥ 10

23

). This was specifically seen between pH 6.5 and 8, showing

a large pH difference needed to trigger a significant increase in vancomycin release.

C HAPTER 4. PP Y /PEGDA C OMPOSITE R ESIN A PPLICATION

69

(a)

(b)

(c)

(d)

(e)

Figure 4.7: pH dependent release of fluorescein at 460 nm over (a) 2 h, (b) 24 h, (c)
7 d and (d) 14 d period from polypyrrole (PPy) nanoparticles (NP) in pH solution alone,
shown in the darker shades, and poly(ethylene) glycol diacrylate resin encapsulated
PPy NPs in pH solutions, shown in lighter shades. The time dependent release comparison (e) showing the extended release characteristics of the NPs alone and resin
encapsulated NPs.
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(b)

Figure 4.8: Vancomycin release from polypyrrole nanoparticles at 2 and 24 h for (a)
nanoparticles alone and (b) nanoparticles encapsulated in resin.

4.4

Discussion

4.4.1

3D Printing

The results from the resolution testing were unexpected given the curing data analyzed in
Chapter 3: PPy/PEGDA Composite Resin Creation. Layer print times were determined
experimentally, based off the UV absorbance of the resin seen in Figure 3.4. Cure
times were increased in 50 s intervals until a solid print was achieved and there was
adequate layer adhesion. After successful curing, the print resolution was evaluated. It
was hypothesized that the print resolution would decrease with the addition of NPs due
to the lower curing efficiency. Conversely, the addition of NPs helped absorb any excess
light. This was why the higher concentration PPy resins were able to better resolve
hole patterns; excess light outside the pattern was being absorbed by the particles
and wasn’t able to cure resin. Over-curing was seen acutely with the 0 PPy sample
because light was easily spread throughout the polymer, outside the given pattern. The
over-curing in the 0 PPy sample helped build up larger-diameter pillars with excess
cured polymer from the smallest diameter print pattern. Further optimization is needed
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to fully test a range of printing parameters such as layer cure time, settling time and
layer thickness, that may allow the creation of even smaller features to be resolved.
Overall, the decease in print resolution can be accounted for in the print parameters
and a larger number of PPy NPs for drug delivery, therefore the 0.5 PPy resin was said
to be the most successful. Comparing these results against other types of 3D printing,
Nguyen et al. (2013) used two-photon printing methods to cure PEGDA with riboflavin
as a photoinitiator. Two-photon printing uses two ultra-short laser pulses to trigger
polymerization at the intersection. Nguyen et al. (2013) was able to create 120 µm
diameter hollow cylinders with a wall thickness of 20 µm, much smaller than the results
outlined above. This type of two-photon method of polymerization is known to have
high resolution, but rely on the light path being able to penetrate into the resin. The
stereolithography methods used in this thesis create thin layers of resin where light only
has to penetrate down 25 µm/layer. Therefore, two-photon curing methods described
by Nguyen et al. (2013) may not be suitable with the dark PPy/PEGDA resins described
in this thesis. Fantino et al. (2018) also used stereolithography printing of PEGDA
and H2 O (40, 60, and 70% (w/w)) and was able to reliably yield 200 µm details. The
printer used by this author had a XY resolution of 39 µm compared to the printer used
in this thesis with a XY resolution of 5 µm. Therefore, it is reasonable that the results
in this thesis yielded smaller diameter features but are still limited by the properties of
PEGDA, H2 O and riboflavin (Cullen, 2018). Comparing these results to extrusion based
printing of conductive hydrogels, Ma et al. (2019) was able to print poly-l-lactide with
PPy NPs using a 260 µm diameter nozzle, which limited their minimum feature size to
260 µm. Vijayavenkataraman et al. (2019) was limited by the 0.8 mm diameter nozzle
used and reported major rheological issues while printing, a significant drawback of
this creation method. Overall, the results presented in this chapter have shown that all
resins were able to achieve minimum feature resolutions smaller than that of current
PEGDA stereolithography printing. These results are important because is has been
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shown that there is an optimal pore size for osteogenesis. Karageorgiou and Kaplan
(2005) found that the minimum pore size was 100 µm for cell migration and ingrowth,
whereas scaffolds with > 300 µm was ideal. The larger pore size allowed the formation
of capillaries, leading to high oxygenation in the area, subsequently increasing the
bone growth (Karageorgiou and Kaplan, 2005). It was seen that all resins were able
to achieve resolutions under the recommended 300 µm. Further testing is needed
to fine tune and characterize the full capabilities of the PPy/PEGDA resins and their
ultimate bone feature resolution. The results outlined in this section have demonstrated
the capability of the PPy/PEGDA resins in terms of print resolution and the application
towards creating patient customized bone grafts.

4.4.2

Drug Delivery

PPy pH drug delivery has been previously described by Samanta et al. (2015) & Liubchak
et al. (2020) and was the basis of this investigation. The theory of PPy pH drug delivery,
touched upon in Chapter 2, is that drug molecules are electrostatically charged onto the
surface of the PPy NPs, the increase in pH causes increased deprotonation of the PPy
backbone, reducing its overall charge and changing the electrostatic interactions that
occur with the dopant molecules. Previous studies have failed to test dopant release from
PPy over a biologically relevant pH range. FL was chosen as it was a molecule that had
previously been tested with PPy NPs and was easily visualized using UV spectroscopy.
FL was incorporated during the PPy NP polymerization process, allowing FL attachment
to the PPy NP. Vancomycin was used a second dopant because it is a common antibiotic
used for Gram-positive infections (Takács-Novák et al., 1993). This positively charged
molecule was vortexed with PPy NPs after creation to protect function but still relied on
the electrostatic interactions between the drug molecule and the PPy NP. The results
outlined from this study showed that there were statistically different increases in FL
release over large pH changes. The NPs alone had an increased FL release between
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pH 8 & 6, 8 & 6.25 and 8 & 6.75, whereas PEGDA encapsulated NPs showed no
statistical difference in FL release at any pH tested. Trends in FL release showed the
this molecule favoured alkaline release conditions and were in line with the referencing
literature. Samanta et al. (2015) showed that FL release was increased with each pH
increment, testing pH 2, 5, 7.4 and 8 after 10 s of vortexing. These increased FL release
in alkaline environments was attributed to the negative charge of FL and the electrostatic
forces the occur with the changing pH values Samanta et al. (2015). The conditions
to trigger significant changes in FL release are contrasted by the pH fluctuations seen
in areas of bone regeneration. It was previously shown that physicological pH of 7.4
fluctuates between 7.28 to 7.54 in areas bone regrowth, reported by Chakkalakal et al.
(1994) using a rat model. Given this, it can be said that the change in pH around
areas of bone regrowth would not cause a significant increase in drug release, although
the entrapped dopant molecules would still be delivered over this pH range. The nonsignificant changes in drug delivery between smaller pH changes may be due to the
variance between n values, which yielded larger than expected standard deviations. It is
hypothesized that this was due to variances in particles creation and drug loading. The
similarity of the PEGDA encapsulated PPy FL release values at the tested pH levels
lead to them being calculated as non-significant. This was expected as the hydrogel
encapsulation was hypothesized to slow PPy pH triggering and add drug diffusion time
into the release parameters. These results are in line with previous work showing that
hydrogel networks heavily impact drug delivery. Huang et al. (2004) used allylamine and
acrylic-acid based hydrogels networks for controlled drug release and found that dextran
release depended on the hydrogel molecular weight and pore size of the hydrogel.
These results highlight the hydrogel results in Chapter 3 and show that further tuning of
the hydrogel may be needed to facilitate optimal drug delivery. One limitation of the FL
polymer release study was that the riboflavin molecule used to cure the PEGDA polymer
showed an absorbance at 460 nm. This meant that any excess riboflavin could leach
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out of the polymer to increase the absorbance value collected. This is hypothesized
to be the reason for the increased FL release values from the hydrogel NPs at the
longer time points, see acutely in the 7 and 14 d data. A second hypothesis for this
increased release could be that the PEGDA gels are affecting the electrostatic and
hydrophobic interactions between the PPy NPs and dopant molecules, triggering a more
efficient dopant release (Samanta et al., 2015). To test these hypotheses, future work
could utilize a fluorescent molecule for drug loading that does not have an absorption at
460 nm.
Riboflavin absorption was accounted for in the vancomycin testing because there was
no overlap between riboflavin and vancomycin at wavelengths over 375 nm. Vancomycin
loading had to be modified from the FL doping since the delicate drug molecule would
not be functional after being solubilized in an acidic SDS mixture. From this, the methods
described by Hosseini-Nassab et al. (2016) for insulin loading of PPy NPs was utilized
and the PPy NPs were vortexed to allow surface attachment of the vancomycin. From
the outlined results, it was shown that this doping method was successful for vancomycin.
For the encapsulated vancomycin-loaded NPs there was a significant increase in release
between pH 6.5 and 8, this may be due to the deprotonation of vancomycin. The
vancomycin molecule has a pKa of 7.75, moving from an overall charge of (+1) to (0),
causing a release from the PPy NPs due to a change in electrostatic interaction between
these molecules (Takács-Novák et al., 1993). It was hypothesized that PPy NPs with
hydrogel encapsulation would allow for an increasingly controlled release compared
to NPs alone. Hydrogel release showed 30.2% dopant release after 2 h compared to
50.7% from the particles alone. After 24 h, the PEGDA encapsulated NPs released 63%
of the dopant molecules whereas the particles showed 51% release, less than a 1%
increase from the 2 h time point. It can be said that the release of NP alone occurred in
the first two hours of being placed into the solution. The remaining 50% may be more
tightly bound to the NPs and therefore require a larger pH change to overcome the
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electrostatic interactions. The PEGDA PPy NPs had an extended release timeline that
occurred after sometime between the 2 and 24 h time points. These results showed the
benefits of the hydrogel entrapment to create a controlled drug release mechanism that
may have increased clinical significance compared to burst release. Comparing release
percentages to other studies, Samanta et al. (2015) showed that PPy NPs alone yielded
approximately 25% peroxicam release after only 10 s of vortexing at pH 8, validating
that the unencapsulated NPs respond quickly to the change in pH. Looking at longer
PPy release studies, Zanjanizadeh Ezazi et al. (2018) showed 80% vancomycin release
from silica particles when combined with gelatin, PPy and hydroxyapatite over a four
month period compared to scaffolds without PPy, which only yielded 50% drug release.
These authors were only interested in a single pH value of 7.4, but did help demonstrate
that PPy has a positive effect on drug delivery, which they attributed to the the positive
chains of PPy repelling the positively charged vancomycin. Additionally, the previous
study was only able to achieve an encapsulation efficiency of 6.5%, compared to 16% in
this thesis. It was hypothesized that a larger drug concentration was entrapped into the
PPy NPs due to the high surface area-to-volume ratio that is a main characteristic of
NPs. This high surface area may also have led to a faster switching method, which is
why there was over 50% dopant release seen in only 24 h. Future studies are needed
to investigate the complex interaction between PPy and vancomycin, but this work has
shown the benefits of combining hydrogels and PPy NPs into a composite material for
drug delivery applications. Additionally, combining the 3D printing capabilities of these
resins could impact the drug delivery capability of these NPs encapsulated in PEGDA.
The geometry could impact the diffusion variables or exposed surface area to control the
release rate to suit a variety of applications. The pH-dependent nature of PPy NPs make
them an ideal candidate for drug release inside the human body where pH fluctuations
are common.
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Chapter summary

The chapter has applied the previously described PPy NPs and PPy/PEGDA resins.
The 3D printing capability of the resins was investigated through the use of a custom
designed stereolithography printer, validating its use to recreate complex bone morphology. Additionally, the drug delivery capability of PPy NPs was tested over biologically
relevant pH ranges, showing higher release at higher pH values. This chapter opens
up new research directions in various types of 3D geometries and dopant molecules
for PPy/PEGDA scaffold drug delivery. The results have demonstrated the capability
of these resins to create patient-customized scaffolds that are capable of drug delivery
inside the human body for improved osteogenic healing.
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Chapter 5
Biocompatibility Testing of Printed
PPy/PEGDA Resin
This chapter outlines the biological testing on the previously described PPy/PEGDA
printed resins. These are vital tests for the proper function for biomaterials and their
applications in-vivo under biological conditions. The cytotoxicity and cell adhesion
of the PPy/PEGDA polymers were tested with pre-osteoblastic cells to understand
these interactions. These evaluations are the first step in the validation of PPy/PEGDA
scaffolds used for bone regeneration.

5.1

Introduction

The success of any biomaterial depends heavily on the ability to interact with the
surrounding tissues. Dee et al. (2002) described the tissue-biomaterial interface as a
complex milieu with chemical, electrical and mechanical interactions occurring. The
purpose of biomaterials is to integrate with the surrounding environment, restoring proper
function without disruption (Dee et al., 2002). Given this information and the successful
creation of PPy/PEGDA polymers, the biological interaction of the material needed
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to be analyzed. The PPy/PEGDA polymers must not be cytotoxic or have cytotoxic
leachates, ensuring no damage to the surrounding cells when used in-vivo. In addition
to cytotoxicity, qualitative cell adhesion with the scaffold material was investigated as
these interactions can dictate cell morphology, viability and signalling. Previous studies
have explored PPy and PEG but this work is the first to investigate the addition of PPy
NPs on the cytotoxicity and cell adhesion of PEGDA. The addition of PPy NPs showed
no adverse cytotoxic effects whereas the cell adhesion was drastically improved. The
results from this work validate that PPy/PEGDA can be used as a biomaterial with
applications in replacing traditional bone grafts.

5.2

Materials and Methods

5.2.1

Materials

MC3T3-E1 pre-osteoblast cells from mouse calvaria were used in all experiments
outlined below. Cell adhesion studies used Minimum Essential Medium-↵ (↵-mem)
(ThermoFisher Cat. #12571063) whereas cytotoxicity testing used Minimum Essential Medium-↵ without phenol red (ThermoFisher Cat. #41061029). Fetal bovine
serum (FBS) (ThermoFisher Cat. #12483020), Penicillin-Streptomycin (ThermoFisher
Cat. #15140122) and Dulbecco’s phosphate-buffered saline (DPBS) (ThermoFisher
Cat. #14190144) were used as received. The CyQUANT XTT Cell viability assay was
used as purchased from ThermoFisher (Cat. #X12223). 100% Ethanol was diluted with
distilled water down to 70% for sterilization purposes. Trypsin was diluted in cell culture
media to 0.25 (w/v). 0.1% Gelatin solution was created and sterilized for cell culture.
PBS was used to create 1% Bovine Serum Albumin (BSA) blocking solution and 0.1%
Triton X-100 solution. Alexa Fluor 488 Phalloidin and Hoechst 33342 were used for cell
staining.
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Methods

Cell culture media was prepared by combining ↵-mem, 10% FBS and 1% penicillinstreptomycin followed by sterile filtration. Cells were maintained by changing culture
media every two days and passaging at 80% confluence with a 1:10 split ratio.
For cytotoxicity testing, the same PPy/PEGDA resins from Chapter 3 were cast
in quadruplicate with an area of 1.2 cm ⇥ 1 cm and a thickness of 1 mm. Cured
polymers were placed into 3 ml of 70% ethanol overnight. The following day, polymers
were moved into a bio-safety cabinet and washed twice with DPBS for 15 min each,
followed by a 30 min cell culture media soak at 37 C. This removed any DPBS salts
or ethanol entrapped in the scaffold. Two polymers were then moved into one new
culture well, totalling 2.4 cm2 of polymer area. According to International Organization
for Standardization (ISO) 10993-12: Section 10.3.3, which defines the surface area to
media volume ratio for cytotoxicity testing, 800 µl of cell culture media with no phenol
red was added to each well. The polymers were incubated for 14 d, 7 d, 72 h and 24 h.
During this time the media quantity was monitored to check if it dropped below 300 µl,
the volume needed for a triplicate test. If the media had evaporated, 100 µl of fresh
media was added. The polymer soaking periods were staggered-started so all media
would reach the desired time point on a single day when the cells were 80% confluent.
Two days before the media reached its time point, MC3T3-E1 cells were passaged into
96-well plates with a cell density of 15,000 cells/cm2 , correlating to 4,800 cells/ well,
with media containing no phenol red. This allowed the cells to reach 80% confluence on
the day of the experiment. Additionally, two triplicates of a standard curve containing 500,
1,000, 2,500, 5,000 and 7,500 cells/ well were plated, the first to measure absorption
values from the XTT assay and the second to perform cell counts. On the day of the
experiment, the original cell culture media was removed and 100 µl of polymer-soaked
media was added to each well in triplicate. A positive control was created by adding
100 µl of media with 35 mmol SDS to promote cell death. The standard curve and
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negative-control media was changed with fresh phenol-red free media. Three wells
with only media were left to serve as blanks. The cells were left to incubate for 24 h.
The following day, the XTT assay was mixed according to the given instructions, 2 ml
of the Electron Coupling reagent was added to 12 ml of the XTT reagent and vortexed.
Directly following vortexing, 70 µl of the XTT solution was added to each test well and
left to incubate for 4 h at 37 C and 5% CO2 . After incubation the plate was protected
from light and moved to a TECAN Safire plate reader and read at 450 nm for XTT
absorption and 660 nm to pick up any debris. The specific absorbance and cell viability
were calculated using the following formulas.

Absor bance = [Abs450 (Test)

% V iability =

Abs660 (Blank)]

[Abs450 (Test)
[Abs450 (Blank)

Abs660 (Test)

Abs660 (Test)]
⇤ 100
Abs660 (Blank)]

(5.1)

(5.2)

The second standard curve was used to gather direct cell counts. 30 µl of trypsin
was added to each well, incubated for 4 min and neutralized by 70 µl of cell culture
media. Cells were counted using a hemocytometer and correlated to the standard curve
absorbance data from the XTT assay.
Cell adhesion studies were completed by curing polymers at various PPy concentrations in 1.2 cm ⇥ 1 cm molds. An analogous preparation method was implemented for
the cell adhesion studies with one change, the cell culture media was extended to 3 h at
37 C. All volumes refer to preparation in standard 12-well plates. Initially, no coatings
were applied to the polymer and the cell were plated directly on top using a monolayer
culture method. Subsequent ECM coatings of 0.1% gelatin or 100% FBS were used
directly after the media soak. 1 ml of 0.1% gelatin or 100% FBS was added to each well,
incubated for 1 h with a 10 min drying period. Plating densities of 5,000, 15,000 and
30,000 cells/cm2 were achieved after completing a cell-count and adjusting the media
volume to 1 ml/ well. The polymers were incubated for five days with media changes
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every other day to ensure there was adequate time for cell adhesion and growth. After
five days, the polymers were carefully moved into an adjacent empty well. Both the
polymer and cell-plating well were stained with Hoechst and Phalloidin stains to visualize
the cell nuclei and cytoplasmic actin, respectively. The cell plating wells acted as a
reference for cell attachment. The staining process was completed as described. Both
the polymer and culture well were twice-rinsed with DPBS before being fixed with 0.1%
PFA for 10 min, followed by two 5 min PBS rinses. A blocking solution of 1% BSA in
PBS was applied for 30 min and washed again with two 5 min PBS rinses. Actin staining
used 800 µl PBS with 20 µl stock Phalloidin. 200 µl of diluted stain was added to each
well and incubated for 20 min with agitation. Two 5 min PBS rinses were completed.
Nuclear staining used 1 ml/well of Hoechst stain (diluted to 1000:1) for 10 min followed
with two 5 min PBS rinses. Cells were imaged using a Leica DMI6000 microscope.

5.3
5.3.1

Results
Cytotoxicity

The cytotoxicity of four PPy/PEGDA formulations were investigated according to the
ISO protocol #10993: Biological evaluation of medical devices, specifically referencing
Parts 5 and 12, Tests for in vitro cytotoxicity and Sample preparation and reference
materials (International Organization for Standardization, 2012). Four time-points for
polymer soaking were chosen: 24 h, 72 h, 7 d and 14 d to exaggerate testing conditions.
These results are summarized in Figure 5.1 and Table 5.1, reported with SE of the mean
(n = 4).
Cell viability was used to compare polymer-soaked media cell activity to the control
wells, calculated using Equation 5.2 as defined by ISO #10993-5 Cytotoxicity - XTT
Assay. The formula used the control well as 100% viability to visualize cell growth/death.
The ISO defines cytotoxicity as <70% cell viability, which was seen in the positive
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Figure 5.1: Cell viability from the XTT assay calculated using Equation 5.2 after
exposure to conditioned media for 24 h. Regular media was used as the negative control
and 35 mmol sodium dodecyl sulfate in culture media was used as the positive control.
There were no significant differences between treatment groups, demonstrating that
no cytotoxic effects from the polymer over a 14 d time period at all PPy concentrations
tested. Reported as the mean with standard error (n = 4).
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Cell Counts (Mean ± Standard Error)
24 h
72 h
7d
14 d
22,300 7,300 20,900 6,700 22,500 8,700 25,200 6,300
19,600 4,600 17,500 6,500 24,400 9,700 26,200 12,700
18,300 6,400 16,900 5,900 24,400 10,800 34,400 19,500
16,700 5,300 17,300 5,200 22,700 7,500 32,900 13,700

Table 5.1: Calculated cells/well from the XTT absorbance data using Equation 5.1 and
the plated standard curves to create a linear formula relating absorbance to cell numbers.
No statistical difference was seen between any the timepoints or PPy concentrations.
Results reported with the standard error (n=4) and rounded to the nearest hundredth.
control of 35 mmol SDS media with a viability of 65%. All polymer samples had an
average cell viability % ranging from 130% (24 h, 0.5 PPy) up to 186% (7 d, 0.25 PPy).
The shorter two timepoints showed minor decreases in the average viability as the
concentration of PPy was increased. The longer timepoints showed no trend between
PPy concentration and average viability. The results showed an increased average
viability when using polymer-soaked media compared to the negative control, but no
significant differences were seen using a one-way ANOVA test with a p-value of 0.05.
Looking at Table 5.1, the 24 and 72 h time points showed similar cell counts for all PPy
concentrations, ranging from 16,700–22,300 cells/well, whereas the 7 and 14 d had
higher average cell numbers between 22,500–34,400 cells/well. Samples from the 72 h
experiment yielded the lowest average cell counts for all PPy concentrations. Conversely,
the 14 d samples yielded the highest average cell counts compared to the three shorter
timepoints for all PPy concentrations. Looking at the SE for the samples, it was seen
that the viability SE mirrors the same trends as the average cell counts, increasing with
the time of polymer-soak. The 14 d samples showed the largest variance, specifically
the 0.25% sample with a SE of ±19, 500 cells/well, four times the smallest SE value
seen with the 24 h, 0.1% sample of ±4, 600.
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Cell Adhesion

Cell adhesion studies were completed in an iterative manner to maximize the bioactivity
of PPy/PEGDA. The un-coated polymers were first tested to see if the MC3T3-E1 cells
would adhere to the PEGDA polymer, with and without 0.1 PPy NPs, seeded at a cell
density of 5,000 cells/cm2 . It was observed that there were no cells adhered to the
surface of either polymer. Phase contrast images were taken to confirm that images
were taken on the polymer surface and not on the plate below. From these results,
the investigation into additional ECM coatings began. To increase the cell adhesion,
two different ECM coatings were applied to the polymers with and without PPy NPs
(0.2 wt% PPy H2 O creation solution) with a higher cell density. Figure 5.2 showed
the cell adhesion on the polymers seeded with a cell density of 15,000 cells/cm2 with
either gelatin or FBS coatings. Qualitative observations from cell images dictated the
coating success. It was observed from the images that there were cells attached to
both coatings, an improvement from the uncoated polymers. The gelatin coating, seen
in panels (a) & (b), showed less pronounced cell spreading (as indicated by actin
cytoskeleton visualization) compared to the FBS coatings, seen in panels (c) & (d).
The number of nuclei were still considered low but were comparable between the two
coatings.
From the coatings results, FBS was selected to be used in future experiments and
the study moved to increasing the PPy NP concentration. Four PPy NP suspension
concentrations (0, 0.1, 0.25 & 0.5 wt% PPy) were incorporated into the PEGDA polymers.
The polymers were seeded at three cell densities to investigate the impacts of PPy
concentration and plating density on cell adhesion. The results of the study were
outlined in Figure 5.3 and Figure 5.4, along with corresponding phase contrast images
in Figure A.1 and Figure A.2. It was observed that there were very few nuclei attached
to the 0 PPy polymers in panels, validating the results of Figure 5.2. The cells on the 0
PPy polymers appeared to be rounded with clusters of nuclei seen with little surrounding
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(b)

(c)

(d)

FBS Coating

(a)

Figure 5.2: MC3T3-E1 pre-osteoblast cells stained with Hoechst (cell nuclei stained
blue) and phalloidin (actin filaments stained green) fluorescent imaging seeded onto
PEGDA polymers, with and without PPy NPs, with two surface treatments. Panels (a)
and (b) were treated with a 0.1% gelatin coating and panels (c) and (d) were treated with
a 100% FBS coating, both plated at 15,000 cells/cm2 . It was observed that the FBS
coating provided better cell attachment, seen through the actin staining in green. This
allowed the qualitative selection of FBS used in the following tests. Scale bar denotes
50 µm.
actin being observed. Qualitatively, with each increase in PPy concentration, there was
a corresponding increase in the cell adhesion of the polymers, demonstrated by an
increased number of nuclei and presence/extended shape of actin fibres. The 0.1 PPy
samples showed similar results to the 0 PPy polymers with low number of cell nuclei
and very little actin being visualized. There was a qualitative increase in the number
of nuclei and actin fibres seen attached to the 0.25 and 0.5 PPy samples at all cell
densities. Specifically, there were larger actin extensions visualized between cells as
opposed to the rounded cells seen on the 0 and 0.1 PPy polymers. Even at the lowest
plating density, there was an increased presence of nuclei imaged with each increase of
PPy concentrations. These images are compared against the control of the surrounding
cell culture plastic, seen in panels (m), (n) and (o) of Figure 5.3. The culture plastic cell
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adhesion showed that none of the PPy concentrations were able to mimic the same
adhesive properties.
Figure 5.4 was collected from the same polymers seen in Figure 5.3 at a higher
magnification to visualize the cell morphology. Higher magnification allowed the visualization of the actin fibres that show cell spreading, a positive sign a cell attachment. The
0 PPy and 0.1 PPy samples again showed rounded actin filaments, pointing towards
a non-adhesive surface inhibiting cell attachment. Additionally, the 0.1 PPy sample
showed distinct clusters of cells attached between PPy NPs, seen in panels (m), (n) &
(o) of Figure 5.4. Cells appeared to favour scaffolds with higher concentrations of PPy
with a qualitative increase in the presence of nuclei. There was also a marked increase
in the visualization of actin filaments in the 0.25 and 0.5 PPy polymers compared to
lower PPy concentrations. The higher PPy concentrations showed clusters of nuclei
with outgrowths of actin connecting each cluster.
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Figure 5.3: MC3T3-E1 pre-osteoblast cells stained with Hoechst (cell nuclei stained
blue) and phalloidin (actin filaments stained green) seeded onto 0, 0.1, 0.25 & 0.5 %
PPy polymers, plated at three cell densities: 30,000, 15,000 & 5,000 cells/cm2 cultured
for 5 d. Compared to the control of the surrounding tissue culture plastic (TCP) in panels
(m), (n) and (o) for 30,000, 15,000 & 5,000 cells/cm2 , respectively. The cell adhesion
qualitatively increased as the amount of PPy was increased, seen by the increased
presence of cell nuclei and actin fibres. Scale bar denotes 150 µm.
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Figure 5.4: MC3T3-E1 pre-osteoblast cells stained with Hoechst (cell nuclei stained
blue) and phalloidin (actin filaments stained green) seeded onto 0.1, 0.25 & 0.5 % PPy
polymers, plated at three cell densities: 5,000, 15,000 & 30,000 cells/cm2 cultured
for 5 d. The cell spreading was qualitatively increased with the addition of PPy NPs,
visualized by the actin fibre extension between nuclei. Panels (m) to (o) demonstrate
the cell adhesion to PPy NPs (marked with red arrows). Scale bar denotes 50 µm.
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All tests used MC3T3-E1 pre-osteoblast cells harvested from mouse calivaria given the
bone regeneration application of these materials. The ISO 10993 - Biological evaluation
of medical devices was referenced heavily during the creation of this experiment to
ensure that proper protocols were followed. The ISO outlined a required 24 h exposure
at 37 C but extended time points were added to better fit the application of this polymer.
Since these materials would stay inside the body, extended polymer soaking time points
up to 14 d allowed the long term impacts to be visualized. An extract method of testing
cytotoxicity was selected because it could facilitate the exaggerated leachate release
from the polymers, not achievable with other methods. Both types of contact testing
(direct and indirect) require the polymer to be in contact with the cell culture media as
cells proliferate and are therefore limited by the media-change or passage frequency.
The XTT assay ((2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]
-2H-tetrazolium hydroxide), referred to as XTT) was chosen because it was a measure
of cell metabolic activity through mitochondrial dehydrogenases (Scudiero et al., 1988).
XTT was reduced in metabolically active cells into a photometric assay which was
related to the cell death caused by polymer leachates.
The cytotoxicity results showed that the developed polymer sterilization protocol
for cell culture was successful. The overnight 70% ethanol soak was long enough to
allow the ethanol to penetrate into the core of the polymer while washing away any
uncured monomers, a main source of cytotoxicity (Liu et al., 2017). Additionally, the
ethanol removed excess riboflavin, which was a large source of autofluorescence during
cell imaging in the Cell Adhesion tests due to its board absorption spectrum, seen in
Figure 3.2. The subsequent DPBS rinses along with the media incubation allowed the
ethanol to be successfully removed before plating cells. The results confirm that the
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protocol outlined in the Methods section yielded a sterilized polymer.
The results from the XTT assay showed the PPy/PEGDA materials were noncytotoxic over the 14 d period. There were no adverse impacts on cell viability from
the polymer-soaked media at any of the four timepoints. The addition of PPy NPs at
concentrations up to 0.5% had no effect on the cell viability compared to PEGDA alone,
showing that the NP dialysis wash removed the acid and SDS that would have killed
the cells. The results of this study was validated through the cell adhesion experiments
will optimal cell growth occurring on the surrounding cell culture plastic alongside the
polymers, seen in panels (m), (n) and (o) of Figure 5.3 for the 0.5 PPy sample. These
results confirm the hypothesis that the polymers would be non-cytotoxic due to the
materials and photoinitiator chosen. PEGDA and PEG derivatives are known to be
bioinert and well-tolerated with a range of cell types (Unagolla and Jayasuriya, 2020;
Zhu, 2010; Liu et al., 2017). The main source of cytotoxicity when working with polymers
is the presence of uncured monomers, which were removed from the prints during
the ethanol soak (Liu et al., 2017). Looking specifically at MC3T3-E1 cell interaction
with PEG, previous research has used PEG in conjugation with poly-lactic acid and
hydroxyapatite for dexamethasone drug delivery that was tested with MC3T3-E1 cells
and showed no cytotoxicity (Li et al., 2018). Additionally, Carles-Carner et al. (2018)
used PEG hydrogels to encapsulate MC3T3-E1 cells with no cytotoxicity. These studies
are in line with our findings that PEGDA had no cytotoxic effects over a 14 d period
on osteoblast cells. Riboflavin was selected as the photo-initiator for this application
because of its compatibility compared to commercially available photoinitiators (Nguyen
et al., 2013). Nguyen et al. (2013) used both PEGDA and riboflavin with GM-7373 bovine
aortic endothelial cells and showed that there was no cell death using a LIVE/DEAD
assay, our results extend these findings to MC3T3-E1 cells. Chaves Neto et al. (2010)
investigated the use of riboflavin in MC3T3-E1 cells in cell culture and showed that it
had no effect on cell-viability, which was validated by the cell-viability results from the 0
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PPy prints in this study. Looking at the results from the increasing PPy concentrations in
PEGDA resin, it was seen that there were no cytotoxic effects due to the PPy NPs and
there were no significant differences between samples or timepoints. Ramanaviciene
et al. (2007) previously showed that PPy NPs tested in the peritoneum of mice had
no cytotoxic effects over a 6-week period. Our findings on PPy NP cytotoxicity with
MC3T3-E1 cells fit with these results. This is encouraging because the PPy NPs used
in this thesis were created with H2 O2 oxidative polymerization methods with an SDS
additive that has not been previously studied. The viability results, seen in Figure 5.1,
showed an overall increase in the cell viability compared to the negative-control, cultured
with regular media. The average cells calculated increased alongside the duration of
polymer-soaking, seen in Table 5.1. The 72 h cell counts were seen to be the lowest
for all PPy concentrations whereas the 14 d cell counts were the largest. This increase
in cell viability over time can be attributed to two working hypotheses. First, the toxic
leachates that are the most cytotoxic to cells are being degraded over time due to the
increased temperature or by components of the cell culture media. This means that the
shorter soaking times kept the cytotoxic elements in the fluid and could be applied to the
cells before degradation. Further studying of the leachates present in the cell culture
media at each timepoint could help elucidate this hypothesis but was not considered in
the scope of this study. Secondly, the release of excess riboflavin that was not removed
during the ethanol soak could have increased the absorption. Additionally, riboflavin
is a component of the ↵-mem media chosen for this cell line at a concentration of
0.1 mg/l and it reported to have a role transferring electrons in the metabolic processes
of cells (Millipore-Sigma, 2021; Thermo-Fisher, 2021; Chaves Neto et al., 2010). This
means that as the polymer leachate time is extended there may be increased levels
of riboflavin in the media that could be facilitating a minor increase in cell metabolism.
To investigate this, a future study could use UV spectroscopy on polymer soaked cell
culture media to calculate the concentration of riboflavin as a function of time to see if
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there is a significant increase. Overall, this study has shown that the PEGDA materials
with 0, 0.1, 0.25 & 0.5 PPy NPs are not cytotoxic to MC3T3-E1 cells over a 14 d period
following the outlined ISO 10993 standards and can be used in future studies as a
composite biomaterial.

5.4.2

Cell Adhesion

Interpreting the results from the cell adhesion studies, in was seen that PEGDA is
not biologically active and alone does not support cell growth. The bio-inert nature of
PEGDA was validated with no MC3T3-E1 cells able to be visualized on the polymer
surface. Previous studies have shown that PEG does not have optimal cell adhesion
but can be modified with various types of molecules to create a bioactive polymer(Zhu,
2010). It was hypothesized that the PPy NPs would add cell attachment points to allow
the cells to adhere to the polymer. PPy was chosen for this application because it
has previously been used with cells for osteogenic applications (Jie et al., 2017; Liu
et al., 2013; He et al., 2017). He et al. (2017) investigated the use of PPy coatings
for bone implants, showing that PPy nano-wires benefitted cell growth compared to
titanium and normal “cauliflower-like” morphology PPy. Chitosan/PPy–alginate bone
scaffolds were created by Sajesh et al. (2013) using chemical synthesis. The scaffolds
demonstrated increased cell proliferation with the addition of PPy-alginate compared
to chitosan only scaffolds with mg-63 osteoblast cells. These works demonstrate the
cell adhesion capability of added PPy. From the pilot test, it was determined that PPy
NPs would have to be used in conjunction with a second method to increase the cell
adhesion of PEGDA.
To increase the cell adhesion of the PPy/PEGDA polymers, ECM coatings were
added as a step before cell plating. Coatings were chosen because they have previously
been used as surface coatings on cell culture plastic and silicone testing equipment,
where certain cells would not normally adhere (Bello et al., 2020; Lee et al., 2019;
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Kim et al., 2020). Gelatin, a natural polymer made of denatured collagen provided
linear proteins that served as cell attachment points alongside the PPy NPs (Bello
et al., 2020). FBS provided similar benefits to gelatin in a non-denatured form that was
hypothesized to offer improved cell adhesion for the PPy/PEGDA polymers. Figure 5.2
panels (a) and (b) with a 0.1% gelatin coating showed that cells were able to adhere
to the polymer. The FBS coatings, seen in panels (c) and (d), had a similar increase
in cell adhesion as gelatin. These results were expected as the ECM components of
both gelatin and FBS coated the polymer surface to act as attachment points and may
have influenced cell signalling. Previous work has shown that ECM proteins bind to
cell receptors and trigger a multitude of downstream cell-signaling effects such as gene
and protein expression (Zhu, 2010). From these initial pilot studies investigating the
ECM coatings, it was chosen that FBS would be used going forward as it qualitatively
showed the a positive effect on actin fibres. With this coating, the impact of modifying
the concentration of PPy NPs could be investigated.
Figure 5.3 and Figure 5.4 both showed a qualitative increase in cell adhesion when
an increased concentration of PPy NPs was incorporated into PEGDA and the cells were
plated at higher densities. Both of these results were expected. The higher cell density
allowed a larger number of cells to be deposited on the polymer, offering an increased
chance of attachment. Additionally, the higher cell densities could have increased cell-tocell interactions and signalling, facilitating adherence. It was hypothesized that the 0.25
and 0.5 PPy polymers offered an increased presence of PPy NPs at the surface and
created a rougher surface for cell adhesion compared to PEGDA. The rougher surface
and increasingly black polymer was seen in Figure 3.5 as the PPy concentration was
increased. Looking at panels (m), (n) & (o) of Figure 5.4 it was noted that the cells were
stretched between clusters of PPy NPs. This finding was seen commonly in the 0.1
PPy samples and points towards cells preferentially adhering to PPy NPs compared
to PEGDA. This finding highlighted the hypothesis that PPy NPs would act as cell
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attachment points and was qualitatively confirmed when imaging the 0.25 and 0.5 PPy
samples but would need further testing to fully elucidate. The higher concentration of
PPy NPs allowed for an increased presence of nuclei and actin filaments attached to the
polymer surface, seen in Figure 5.4. This hypothesis may be supported by the results
outlined by Schexnailder et al. (2010) with polyethylene oxide, another polymer that does
not support cell adhesion. This author used added silicate NPs in polyethylene oxide, but
cell adhesion and proliferation was only achieved with higher concentrations (<40 wt.%)
of silicate NPs. The best cell adhesion was seen with 70 wt.% silicate NPs, a much
higher concentration than the maximum PPy NP concentration chosen for this study.
Gaharwar et al. (2013) incorporated silica nanospheres into PEG hydrogels to increase
the fibroblast adhesion. PEG with 1, 5 and 10% silica nanospheres showed an improved
cell adhesion with each % increase, matching the results seen in our study. These
studies are in line with the trends outlined in the results section with smaller percentages
of PPy incorporated into the PEGDA resin tested. The concentration of NPs added into
the PPy/PEGDA resin was limited due to the UV curing inhibition described in Chapter 3.
From the results of this study, it was concluded that the addition of PPy NPs provided a
qualitative increase in cell adhesion compared to PEGDA alone and that the 0.25 and
0.5 PPy polymers allowed a marked increases in nuclei attached and actin filaments
between cells. A significant concentration of PPy NPs was not added to the PEGDA
hydrogels to define them as an optimal cell binding surface compared to cell culture
plastic, but the results provide insight into finding the critical % of PPy for cell adhesion.
Future studies should include methods to allow increased PPy at the polymer surface
through interfacial PPy polymerization or by overcoming the UV curing challenges that
accompany the addition of PPy NPs. All materials tested in this study were cured with
no surface modification or topographic alterations to allow a controlled environment to
visualize only material composition impacts. The benefits of 3D printing PPy/PEGDA
resin is that these parameters can be modulated to enhance cell attachment. de Vicente
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and Lensen (2016) showed that surface-level topographic patterns on PEG materials
induced fibroblast adhesion. Future work could include 3D printing complex structures
that may have a positive impact on cell adhesion. Additionally, the conductive nature of
PPy would allow electrical stimulation cells plated on the PPy/PEGDA scaffolds, which
has previously been shown to increase osteoblast growth (Liu et al., 2013; He et al.,
2017).

5.5

Chapter summary

This chapter has covered the biological testing of the PPy/PEGDA polymers to ensure
they are capable of being used inside the human body. Cytotoxicity testing showed that
PEGDA polymer cured with riboflavin containing various concentrations of PPy NPs
were biocompatible over a 14 d period. Following defined ISO methods on cytotoxicity
mean that these results are standardized and can have wide impacts on researchers
using PEGDA and/or PPy in biomedical applications. Cell adhesion studies showed
that the addition of PPy NPs did increase the cell adhesion of PEGDA, qualitatively
increasing the presence of nuclei and connecting actin filaments.
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Chapter 6
Concluding remarks
6.1

Summary of conclusions

This thesis has explored the creation and application of a composite PPy/PEGDA
biomaterial for osteogenic applications. The findings ascertained through these studies
have prompted the following conclusions:
1. PPy NPs can be successfully incorporated into photoactive PEGDA resins that are
capable of being cured using riboflavin as a natural photoinitiator. This process
entailed a two-step creation methodology of the composite resin, first the PPy
NPs were formed using oxidative polymerization and added to the PEGDA resin.
A novel PEGDA, TEA and riboflavin resin was developed to compliment the PPy
NPs that avoided the use of potentially cytotoxic curing methods. The successful
PPy/PEGDA composite polymer showed comparable conductivity to bone tissue
along with novel findings into the impact of PPy on the hydrogel swelling ratio.
2. PPy/PEGDA resin was shown to be a successful stereolithography printing resin
for the creation of complex microarchitectures. The impact of PPy NPs on hydrogel print resolution was investigated and showed that the NPs benefitted feature
resolution by reducing over-cure. Resins were able to achieve features smaller
101
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in diameter than required for optimal osteogenic activity in bone scaffolds. Additionally, the resins were able to mimic complex osteogenic morphology for the
creation of patient customized bone grafts.
3. PPy NPs are capable of pH-dependent drug delivery that can be modulated to
suit a wide variety of applications when used in-vivo. Modelling of dopant release
using FL showed the pH dependent release over a biologically relevant pH range.
Additionally, a novel entrapment method for vancomycin was deemed successful
that has applications for the delivery of various pH-sensitive molecules. The
PEGDA encapsulation of PPy NPs allowed for a controlled release of vancomycin
that has increased clinical significance as opposed to burst dopant release.
4. Finally, the biological testing of the PPy/PEGDA polymers showed no cytotoxicity
and improved cell-adhesion with the incorporation of PPy NPs. MC3T3-E1 cells
integrated onto the polymer surface and showed the potential of this material to
be used as a cell scaffold for improved bone regeneration.

6.2

Summary of contributions

The most significant research contributions presented in this thesis are summarized as
follows:
• The first-ever study on the creation of a photoactive PPy/PEGDA resin utilizing
riboflavin as a photoinitiator that is capable of being cured using UV light. Development highlighted the NP creation methods combined into a hydrogel format
to develop a composite biomaterial. Characterization of the impact of PPy NPs
on the hydrogel allowed the functional properties of the composite material to be
understood.
• A novel study into the 3D printing characteristics of PPy/PEGDA riboflavin resin
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using stereolithography techniques. The resin formulations allowed the creation
of complex, high-resolution 3D structures that are capable of mimicking bone
microarchitecture.
• The first study on the pH-dependent drug delivery from PPy NPs over a biologically
relevant pH range for in-vivo applications. Testing included FL and vancomycin
release at various time points that help elucidate the pH drug delivery mechanism
and apparent efficiency with a focus on biologic applications. Integration of PPy
NPs into hydrogels allowed for an increasingly controlled release mechanism.
• A new perspective on the biocompatibility and cell adhesion impact of PPy NPs
when incorporated into PEGDA hydrogels. A full wash and sterilization procedure
for hydrogels was created to complement this study. The results showed integration
of pre-osteoblast cells on the scaffold surface with exposed PPy NPs that support
its use as a cell scaffold for osteogenic applications.

6.3

Recommendations for future research

The hydrogel analysis in this thesis provided valuable information into the formation of UVcrosslinked PEGDA hydrogels and the impact that PPy NPs have on this phenomenon.
As described in Chapter 3, increased testing is need to understand the impact of PPy on
the swelling ratio, as it is was seen to decrease with NP addition. Wettability and contact
angle tests of composite material would help understand these interactions. Additionally,
further tuning of the hydrogel matrix properties would allow efficient drug delivery of
specific molecules and add a second drug release control parameter, outside of pH.
The 3D printing parameters of this thesis serve as a base for future studies. Further
tuning of the depth of cure, layer height, layer cure time and settling time could all lead
to the definition of smaller features than were reported in this thesis. The capabilities of
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3D printing can also be extended to the drug delivery and biological testing sections.
Specifically, the creation of complex scaffold that increase diffusion rates or surface area
ratios would heavily impact the drug release rates and could be modified based on the
desired application. For biological testing, only flat polymers were studied to exclude any
confounding effects of 3D morphology that could affect the cell adhesion data collected.
The printing of complex microstructures could help further improve the cell adhesion of
these materials.
To advance the biological testing of these materials, future studies could look at
quantification of the cell adhesion data to solidify the relationship outlined in this thesis.
Additionally, testing of the cell gene expression after being seeded onto the polymer
would be useful. This could help elucidate the complex cell interactions that are occurring
between the biomaterial and the cell signalling pathway. Future in-vivo testing could
include mouse models that simulate large skeletal defects, measuring the bone ingrowth
and calcification with these PPy/PEGDA scaffolds.
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Figure A.1: Hoechst and phalloidin stained cells images for 0, 0.1, 0.25 & 0.5 % PPy
polymers, plated at three cell densities: 5,000, 15,000 & 30,000 cells/cm2 along with
the phase contrast images to allow insight into the polymer surface that facilitates cell
adhesion.
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Figure A.2: Hoechst and phalloidin stained cells for 0.1, 0.25 & 0.5 % PPy polymers,
plated at three cell densities: 5,000, 15,000 & 30,000 cells/cm2 . The cell spreading
was qualitatively increased with the addition of PPy NPs, visualized by the actin fibre
extension between nuclei.
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